Design and Synthesis of Shape-Persistent Arylene-Ethynylene Covalent Organic Polyhedrons through Alkyne Metathesis and Their Fullerene-Binding Study by Wang, Qi
University of Colorado, Boulder
CU Scholar
Chemistry & Biochemistry Graduate Theses &
Dissertations Chemistry & Biochemistry
Summer 7-18-2014
Design and Synthesis of Shape-Persistent Arylene-
Ethynylene Covalent Organic Polyhedrons
through Alkyne Metathesis and Their Fullerene-
Binding Study
Qi Wang
University of Colorado Boulder, qi.wang.cu@gmail.com
Follow this and additional works at: http://scholar.colorado.edu/chem_gradetds
Part of the Chemistry Commons
This Thesis is brought to you for free and open access by Chemistry & Biochemistry at CU Scholar. It has been accepted for inclusion in Chemistry &
Biochemistry Graduate Theses & Dissertations by an authorized administrator of CU Scholar. For more information, please contact
cuscholaradmin@colorado.edu.
Recommended Citation
Wang, Qi, "Design and Synthesis of Shape-Persistent Arylene-Ethynylene Covalent Organic Polyhedrons through Alkyne Metathesis
and Their Fullerene-Binding Study" (2014). Chemistry & Biochemistry Graduate Theses & Dissertations. Paper 6.
  
 
DESIGN AND SYNTHESIS OF SHAPE-PERSISTENT ARYLENE-
ETHYNYLENE COVALENT ORGANIC POLYHEDRONS 
THROUGH ALKYNE METATHESIS  
AND THEIR FULLERENE-BINDING STUDY 
by 
Qi Wang 
B.S., Peking University, Beijing, China, 2009 
 
 
A thesis submitted to the  
Faculty of the Graduate School of the  
University of Colorado in partial fulfillment  
of the requirement for the degree of  
Doctor of Philosophy 
Department of Chemistry & Biochemistry 
2014 
 
 
This thesis entitled: 
“Design and Synthesis of Shape-Persistent Arylene-Ethynylene Covalent Organic Polyhedrons 
Through Alkyne Metathesis and Their Fullerene-Binding Study.” 
written by Qi Wang 
has been approved for the Department of Chemistry & Biochemistry 
 
 
 
 
___________________________ 
Wei Zhang, Ph. D. 
 
 
 
 
 
___________________________ 
David Walba, Ph. D 
 
 
 
Date ______________________ 
 
The final copy of this thesis has been examined by the signatories, and we 
Find that both the content and the form meet acceptable presentation standards 
Of scholarly work in the above mentioned discipline.  
   iii 
 
 
Thesis Abstract 
 
Wang, Qi 
(Ph.D., Department of Chemistry & Biochemistry) 
Design and Synthesis of Shape-Persistent Arylene-Ethynylene Covalent Organic Polyhedrons 
through Alkyne Metathesis and Their Fullerene-Binding Study 
Thesis directed by Prof. Wei Zhang 
 
Shape persistent 2-D macrocycles constructed via alkyne metathesis have been well 
explored in the past decade. However, 3-D Covalent Organic Polyhedrons (COPs) synthesized 
through alkyne metathesis have been rarely studied. The objective of the work described in this 
thesis is to explore the efficient assembly of 3-D shape-persistent covalent organic polyhedrons 
through dynamic alkyne metathesis and study the relationship of the COP structures and the 
geometry of their building blocks. The applications COPs in host-guest chemistry, specifically 
the interactions with fullerenes will be discussed. 
In Chapter 1, an overview of the current advances in alkyne metathesis reactions and 
their application in organic materials development, including design and synthesis of novel 
polymers, shape-persistent 2-D macrocycles, 3-D molecular cages and porous frameworks.  
In Chapter 2, the design and synthesis of a tetrameric COP with an unexpected D2h 
symmetry through one-step alkyne metathesis from a C3 symmetrical monomer is discussed. The 
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COP structure was confirmed by the signal crystal X-ray diffraction. This COP exhibits high 
binding affinity with C70 over C60 (KC70/KC60 > 1000).  
In Chapter 3, the synthesis of a dumbbell-shape tetrameric COP through alkyne 
metathesis is discussed. The formation of the tetrameric structure instead of entropically- favored 
dimeric one is investigated through computer modelling study. The cage also serves as a host for 
fullerenes.  
In Chapter 4, the relationship between cage structures and the geometry of monomers in 
the dynamic assembly process is discussed. A dimeric cage and its interlocked cages were 
obtained in one-pot alkyne metathesis starting from an extend C3 symmetry monomer. 
In Chapter 5, the design and synthesis of a series of pyrene based COPs are described. 
These COPs exhibit strong fluorescence and significant binding affinity with fullerenes. They 
can be transferred into cells, which have potential applications in diagnosis. A water soluble 
pyrene cage was also synthesized and its biological property study is undergoing.  
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CHAPTER 1 
 
 
 
Recent Applications of Alkyne Metathesis in the  
Synthesis of Organic Materials  
 
 
 
1.1. Introduction 
Alkyne metathesis was first discovered in 1968 while 2-pentyne was scrambled into 2-
butyne and 3-hexyne by WO3 immobilized on silica (6.8% w/w) at 350oC.1 Unlike the olefin 
metathesis, however, the impact of alkyne metathesis on organic synthesis is not very remarkable, 
mainly due to relatively low reactivity and limited functional group tolerance of alkyne 
metathesis catalysts.   
After the discovery of alkyne metathesis, a few mechanisms were proposed, and the one 
proposed by Katz and McGinnis (Scheme 1.1) was later experimentally verified by Schrock.2-4 
The metal-carbon triple bond (carbyne) reacts with an alkyne first to form a [2+2] cycloaddition 
intermediate, which is followed by a cycloreversion to generate a new carbon-carbon triple bond.  
Schrock, as one of the key pioneers in the alkyne metathesis catalyst development, 
initiated the Schrock-type alkylidyne complexes (RC≡MX3) containing tungsten or molybdenum 
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and carbon triple bond.5 This type of catalysts exhibit high activity and allow metathesis 
reactions to occur at lower temperature (25 oC). However, the small alkyne polymerization 
(Scheme 1.1) as a main side reaction remained as a key problem limiting the wide and scaled-up 
applications of alkyne metathesis which is due to two open binding sites in this type of catalysts. 
The mechanism of the polymerization is that small alkyne can repeatedly insert into the metal-
carbon bond and form polymers through ring expansion mechanism.2,6 Thus the generated 
molybdenum(VI) vinyl alkylidene species would be unavailable for further alkyne metathesis.  
 
Scheme 1.1. General mechanism for desired alkyne metathesis and undesired polymerization of 
small alkyne substrates. 
Recent studies by the Zhang group showed that blocking one alkyne binding site, either 
chemically through coordination or physically through spatial blocking, can efficiently prevent 
the small alkyne polymerization. Moreover, these amine, ammonium and silane based 
multidentate catalysts (1–3) exhibit high activity, great functional group tolerance, high stability 
as well as long life time. These catalysts can catalyze nitro and formyl substituted 
phenylpropynes which are considered tough substrates for alkyne metathesis.7-9 
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Scheme 1.2. Multidentate alkyne metathesis catalysts developed by the Zhang group.  
A significant amount of efforts was also devoted to design and synthesis of user-friendly 
catalysts.10-11 The Fürstner group designed and synthesized a series of bench-stable precatalysts, 
which can be further activated by adding MnCl2 or ZnCl2. The nitride precatalyst 4 are stable 
under air for 2 years and the generated activate species showed good activities for most of 
substrates except aldehydes and acid chlorides. Later, the alkylidyne precatalyst 8, which can 
also be activated by MnCl2 or ZnCl2 to generate active species 9 with improved activity and 
stability, was synthesized.  
 
 
Scheme 1.3. Bench-stable precatalysts and their activation. 
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1.2. Applications of alkyne metathesis in organic materials synthesis. 
Alkyne metathesis has been intensively utilized in total synthesis of natural products from 
its discovery12, which will not be covered in this chapter. This introduction will focus on the 
important role of alkyne metathesis in the synthesis of organic materials, including polymers, 2-
D and 3-D well defined, shape-persistent organic molecules and frameworks. 
1.2.1. Applications of alkyne metathesis in polymer synthesis 
Poly(phenylenethynylene)s (PPEs) have attracted tremendous attention in the past two 
decades because of their great applications in light-emitting diodes, organic photovoltaics, field 
effect transistors, et al.13-15 Conventionally, the classic Heck-Cassar-Sonagashia-Hagihara 
reactions are used to synthesize PPEs. However, the potential drawback of the coupling reactions 
is that they often generate diyne defects, which will add uncertain factors to the electron property 
of the materials.16 In contrast, with alkyne metathesis, there will be no diyne defects generated 
based on the metathesis mechanism. Moreover, only one type of monomer synthesis is needed 
instead of the requirement for both terminal acetylenes and aryl halides in the coupling approach.  
In 1997, Weiss, Bunz and Müllen used alkyne metathesis for the first time to synthesize 
PPEs with comparable molecular weight as the polymers obtained through Pd-catalyzed 
coupling reactions, thus opening the door to PPE synthesis through a totally new approach - 
acyclic diyne metathesis polymerization (ADIMET).17 Later, the Bunz group modified the 
reaction condition by using Mo(CO)6/phenol system, which led to high yields of PPEs with 
different substitutes and competitive  degree of polymerization.18   
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Scheme 1.4. PPE synthesis through ADIMET. 
Recently, Zhang and coworkers used the triphenol ammonium coordinated catalyst 2 
successfully synthesized porphyrin-based arylene ethynylene polymers.8 Only one ethynylene 
carbon signal was observed in 13C NMR spectrum, thus indicating defect-free conjugated 
porphyrin-based polymers formed.  
 
Scheme 1.5. Synthesis of porphyrin-based arylene ethynylene polymers using alkyne metathesis. 
Later the Qin group and Zhang group using the triphenolsilane coordinated catalyst 3 
successfully synthesized the polydiacetylenes (PDAs) through Acyclic Enediyne Metathesis 
Polymerization (AEDMET).19 PDAs are well studied as conjugated polymers because of their 
applications in chemo and bio-sensing under stimulations.20-21 However, conventionally PDAs 
can only be obtained through solid state polymerization which requires strict periodic packing in 
crystals. This represents the first time that solution-processable PDAs are synthesized through 
solution polymerization using AEDMET. The device fabricated from the PDAs exhibited over 
100-fold cell performance than previously reported PDAs synthesized via solid state 
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polymerization. It is worth pointing out that these PDAs could not be obtained using either 
Schrock catalyst or Mortreux–Mori–Bunz catalyst, thus indicating the great advantage of such 
multidentate alkyne metathesis catalysts in PDA synthesis.  
 
Scheme 1.6. Synthesis of PDAs using alkyne metathesis. 
The ring-opening alkyne metathesis polymerization (ROAMP) has also been explored. 
The first reported ROAMP was conducted by Schrock and coworkers in 1987.22-23 They found 
that strained cyclooctyne can undergo ring-opening polymerization catalyzed by [(tBuO)3-
Mo≡CPr], giving high molecular weight polymers but also with high polydispersity (PDI > 4). 
This finding suggested that this polymerization was not living and the catalyst could not 
distinguish between the strained alkyne bonds in cyclic monomers and those internal alkyne 
bonds in polymers. In order to achieve living ROAMP, the catalyst should have mild activity 
which can only react with strained alkynes without touching the polymer backbones so that no 
“back-biting” would occur. Nuckolls and Fisher recently screened a series of catalysts for 
ROAMP. Interestingly, when catalyst 18 was used to catalyze the ROAMP, at the initiating stage, 
the polymer product showed low PDI and high molecular weight (t < 15 s). However, when all 
monomers were consumed, the cross metathesis (back-biting) was observed, showing broad 
product distributions. Among all different ligands for molybdenum based catalysts, catalyst 19-
21 gave narrow PDI and high molecular weight for polymer 17c. Later, the Nuckolls group 
developed a new type of phenoxide-based catalyst 23 showing fast initiation and slow chain 
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propagation. This metathesis reaction showed low PDI (PDA=1.2) as well as predicted molecular 
weight with monomer 16d.24 Most recently, starting with the triphenolamine coordinated Mo(VI) 
carbyne complex (1, without nitro) developed by the Zhang group, Nuckolls and coworkers 
activated it by MeOH in situ. The MeOH dissociation from the molybdenum catalyst 23f with 
mild activity enabled the slow chain propagation. This catalyst does not require aprotic 
environment and catalyzes 16d efficiently within 2 h.25  
 
Scheme 1.7. Synthesis of polymer 17 using alkyne metathesis.  
Table 1.1 Polymerization results of different monomer 16 using different catalysts. 
catalysts 
16a: 
R1=R2=H 
R3=H12H25 
16b: 
R1=H 
R2=Br 
R3=C12H25 
16c: 
R1=R2=Br 
R3=C12H25 
16d: 
R1=R2=H 
R3=TIPS 
16e: 
R1=R2=R3=
H 
 
17a: 
Mn=54,000 
PDI=2.0 
 
17b: 
Mn=54,000 
PDI=2.6 
 
17c: 
Mn=32,000 
PDI=1.8 
 
NA NA 
 
NA NA 
17c: 
Mn=19,300 
PDI=1.1 
NA NA 
 
NA NA 
17c: 
Mn=248,000 
PDI=1.3 
NA NA 
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catalysts 
16a: 
R1=R2=H 
R3=H12H25 
16b: 
R1=H 
R2=Br 
R3=C12H25 
16c: 
R1=R2=Br 
R3=C12H25 
16d: 
R1=R2=H 
R3=TIPS 
16e: 
R1=R2=R3=
H 
 
NA NA 
17c: 
Mn=170,000 
PDI=1.3 
NA NA 
 
NA NA NA 
17d: 
Mn=3,900 
PDI=1.2 
NA 
 
f: R=H 
g: R=NO2 
NA NA NA 
17d: 
f: Mn=3,200 
 PDI=1.2 
g: Mn=6,300 
 PDI=2.4 
17e: 
f: Mn=6,300* 
 PDI=1.3* 
* After two steps: alkyne metathesis followed by (iPr)3SiCl, Et3N, 72%. 
1.2.2. Applications of alkyne metathesis in synthesis of macrocycles, molecular cages and 
frameworks  
The synthesis of well-defined macrocycles and molecular cages represents a challenging 
task when traditional step-by-step coupling reactions are utilized. On the other hand, dynamic 
covalent chemistry (DCvC), as a powerful synthetic approach for thermodynamically favored 
products through fully reversible covalent reactions, has been utilized to synthesize well-defined 
molecular architectures. Alkyne metathesis, as one type of DCvC, has been utilized to synthesize 
shape-persistent macrocycles, molecular cages and frameworks. Under alkyne metathesis 
conditions, the carbon-carbon triple bonds can exchange with one another and the systems can 
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undergo “self-correction” procedures to generate the most stable products after reaching 
equilibrium. Also because of the linear and rigid nature of alkyne groups, the ethynylene-linked 
products will be robust and shape-persistent.  
1.2.2.1. Alkyne metathesis applications in the synthesis of 2-D shape-persistent macrocycles  
There have been great interests in shape-persistent arylene ethynylene macrocycles 
(AEMs) as building blocks for supramolecular materials due to their novel properties. The first 
reported AEM was synthesized by the Staab group back in 1974 with only 4.6% yield.26 The 
method used was six-fold Stephens-Castro coupling. Later, Sonogashira coupling was widely 
used to synthesize this type of macrocycles. Such cross-coupling based synthetic approach is 
generally efficient and has wide functional group tolerance. However, its big disadvantage is that 
the product distribution is kinetically controlled, thus stringent reaction conditions, such as 
concentration and temperature, are needed.  
In the past one decade or so, people have explored the synthesis of arylene ethynylene 
macrocycles via alkyne metathesis. The first reported AEMs were synthesized by the Bunz group 
in 2000.27 Even though the final product was a mixture of polymers (major) and macrocycles 
(minor), presumably due to low activity of the catalyst, it showed the possibility of synthesizing 
AEMs via alkyne metathesis. Three years later, the Whitener and Vollhardt groups synthesized 
triangle macrocycles 24 and rhombus-shaped macrocycles 25 via alkyne metathesis in good 
yields. More impressively, ortho-dehydrobenzannulenes 26 was also obtained.28  
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Scheme 1.8. Synthesis of triangle macrocycle 24, rhombus macrocycle 25 and ortho-dehydro-
benzannulenes 26.  
Later, Moore and coworkers systematically studied the dynamic feature of AEM 
formation via alkyne metathesis.29-32 In order to drive the reaction to most favored macrocycle 
products more efficiently, precipitation-driven method was developed. Given the development of 
phenol-based alkyne metathesis catalysts and precipitation driven method, the yields of the 
desired hexameric phenylene ethynylene macrocycles 27 starting from meta-disubstituted 
benzenes were significantly improved to 80%, and the tetrameric carbazole based macrocycles 
27 were obtained in 84% yield. Moore and coworkers also confirmed the dynamic nature in the 
macrocycles 26 formation by monitoring the reaction progress by gel permeation 
chromatography (GPC), which showed long oligomers (> 6 repeating units) are formed at the 
early stage of the reaction and then slowly converted back to more stable hexameric 
macrocycles.31 These observations illustrated that oligomers formed quickly by losing end 
groups, however under reversible conditions, macrocycles have lower free energy than oligomers 
(entropy drivien), thus lower energy species enriched at the equilibrium and large oligomers 
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transformed into macrocycles. Interestingly, besides hexamers, pentamers and heptamers were 
also observed as minor species. Comparing hexameric macrocycles with oligomers, the enthalpy 
was very similar because they both have minimum angle strain. But the entropy of macrocycles 
was much higher because a larger number of molecules are formed than the oligomer/polymer 
case. Pentameric macrocycles was less favored because its higher angle strain increased the 
enthalpy; heptameric or even octameric macrocycles decreased the number of molecules 
resulting in less entropy contribution, therefore these macrocycles did not exist as major species. 
Scrambling experiment between two hexameric AEMs with different side chains was conducted 
and fully scrambled products were observed on MALDI-MS. This experiment revealed the full 
reversibility of carbon-carbon triple bonds formation of these phenylene ethynylene macrocycles 
under alkyne metathesis condition, further supporting that these macrocycles are the most 
thermodynamically favored products.  
 
Figure 1.1. The cyclooligomerization energy landscape. As the degree of conversion increases, 
the end groups are removed, driving the reaction to oligomers and macrocycles. The energy gap 
(∆Ggap) is the engergy difference between the most stable product and the second stable product. 
The engergy landscape determines the final products distribution under reversible conditions. 
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Scheme 1.9. Synthesis of macrocycles 27 and 28. 
 
Figure 1.2. Time cousre of macrocycle formation of 27a through alkyne metathesis monitored 
by GPC data.  
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Scheme 1.10. Scrambling experiment of 27a and 27b.  
Very recently, Moore and coworkers developed so-called depolymerizaiton–
macrocyclization method to synthesize AEMs from polymers through alkyne metathesis.33-36 The 
advantage of depolymerizaiton-macrocyclization is to avoid using not very atom-economic 
precipitation driven method to drive the alkyne metathesis to completion. They studied the 
depolymerizaiton from both carbazolylethynylene polymers and carbazolylbutadiyne polymers. 
Unsurprisingly both cases showed low molecular weight species formed in high yields. From the 
carbazolylethynylene polymers as starting polymers, single species AEM 28 was form, which is 
the same product as starting from diyne carbazole monomers. Interestingly, the metathesis 
products starting from carbazolylbutadiyne polymers were mixtures of macrocycles 28 and 32 
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with different numbers of diyne incorporated which was observed on MALDI-MS. This 
observation can be easily rationalized by little free energy differences between these macrocycles.  
 
 
Scheme 1.12. Synthesis of 28 and 32 using depolymerization-macrocyclization of 
carbazolylethynylene and carbazolylbutadiyne polymers. 
Later the Moore group conducted another interesting study showing that, by using more 
flexible, directional-defining ester linker polymers MM and OP, the nondirectional alkyne 
macrocycles distributions via alkyne metathesis are highly related to the relative position of 
alkyne bond and ester group. The products from polymer MM after metathesis showed a wide 
product distribution, macrocycles 33-[x]mer with the number of building blocks from 3-8. In 
great contrast, from polymers OP, the product distribution was much narrower, showing only 3 
and 4 building blocks in one macrocycle 34-[x]mer. Among all the AEMs, the esters’ direction 
varies in the 33-[x]mer, because meta-substitution alkynes on both sides of ester group gave no 
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energy difference on all possible AEMs. For comparation, the otho- and para- substituted 
alkynes on two sides of one ester group show dramatic energy difference on different 
macrocycles, thus only resulting in two possible macrocycles.35 This study provided some insight 
into how the geometries, shapes, and degrees of freedom affect the product distributions through 
dynamic covalent chemistry, and could guide future rational design of 2-D macrocycles.  
 
 
Scheme 1.13. Synthesis of 33 and 34 from polymer MM and OP using depolymerization-
macrocyclization method. 
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1.2.2.2. Alkyne metathesis applications in the synthesis of 3-D shape-persistent molecular cages 
In recent years, discrete 3-D organic cage molecules have attracted great attention due to 
their unique properties and wide applications.37 With their intrinsic porosity, shape-persistent 
cage compounds have been studied in gas adsorption, gas separation (e.g., CO2/N2 or CO2/CH4 
separation)38-40, guest recognition41-44, as well as molecular “flasks”45. Moreover, their great 
potential in newly explored applications such as catalysis and drug delivery is highly attractive.  
However, nowadays, most commonly used dynamic metathesis reactions for organic cage 
molecules are imine condensation/metathesis38-41,46 and boronic acid and diol condensation43,47. 
Alkyne metathesis, which has been successfully utilized in synthesis of 2-D shape-persistent 
macrocycles, has not been fully explored in synthesizing 3-D molecular cages. Only until very 
recently, the Zhang group further expanded the application of alkyne metathesis to the field of 3-
D organic cage synthesis.42,44 In order to sufficiently synthesize 3-D cages, highly active 
catalysts are desired, because during the reaction process, long cross-linked oligomers will form 
in the early stage in light of the previous study of 2-D macrocycle synthesis, and to form the 
most thermodynamic favored product, extensive bond breaking and formation is needed. For the 
first time, the Zhang group designed and synthesized a shape-persistent rectangular prism 
molecular cage by using precipitation-driven alkyne metathesis and with high yield. This 
porphyrin-based molecular cage shows over 1000 times selectivity with fullerenes C70 over C60. 
The computational modeling showed that the height of the cage only decreased slightly 
comparing with the fullerene bound cage, indicating that the ethynylen-linked cage is highly 
shape-persistent.42 In the follow-up study, a two arm porphyrin-based macrocycle showed higher 
fullerene binding with C84 vs C70. It was observed that in the solution phase, this macrocycle 
tended to collapse (supported by variable-temperature NMR experiments) and in the presence of 
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guest molecules, the cages expanded to adapt the guests.44 These results clearly showed that this 
macrocycle has more adapted size and favored to bind larger fullerenes.   
        
Figure 1.3. Synthesis of porphrin-based macrocycle 34 and cage 35 and their molecular models 
of C84@34 and C70@35.  
 
Table 1.2. The association constants of 34, 35 with different fullerenes.  
  KC60 (M
-1) KC70 (M
-1) KC84 (M
-1) 
34 1.γ x 104 β.0 x 106 β.β x 107 
35 1.4 x 105 1.5 x 108 β.4 x 107 
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Figure 1.4. Molecular modeling of free 34 and 35 and C84@34 andC70@35. a, top view of free 
34; b, side view of free 34; c, side view of C84@34; d, top view of free 35; e, side view of free 35;  
f, side view of C60@35. 
 
1.2.2.3.Alkyne metathesis applications in the synthesis of poly(aryleneethynylene) networks. 
There has been growing interest in purely organic porous materials over the past one 
decade because of their widespread applications in gas adsorption/separation, molecular 
recognition and so forth. The purely organic porous materials are generally constituted of C, H, 
O, N, B atoms with covalent bonds. The covalent organic frameworks (COFs) are great 
candidates for gas adsorption because of their high Brunauer−Emmett−Teller (BET) surface 
areas and low density. DCvC, such as imine condensation/metathesis, boronic acid-diol 
condensation48-51 and boronic acid condensation51-52, was utilized in synthesizing COFs. Under 
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reversible conditions, the materials can undergo “self-correction” mechanism so that the defects 
in the materials can be minimized to obtain more ordered structures.   
Alkyne bond, considered as a robust and shape-persistent covalent bond, has great 
potentials in construction of COFs. Recently the Zhang group has explored the 
poly(aryleneethynylene) (PAE) network synthesis using alkyne metathesis for the first time and 
studied the materials performance difference between PAE synthesized via alkyne metathesis vs. 
Sonogashira coupling reactions.53  The designed 2-D polymer and 3-D framework were 
synthesized using these two different methods and at three different temperatures for comparison. 
The PAEs synthesized from alkyne metathesis from 3 different temperatures all showed higher 
BET surface areas than that synthesized from irreversible Sonogashira coupling reactions. 
Although the researchers did not observe the crystallinity of the PEAs, the higher pore size 
analysis showed that the pore size of PEAs through alkyne metathesis is more uniformed. This 
finding proved that the reversibility of alkyne metathesis helped forming more ordered materials.   
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Scheme 1.14. Synthetic scheme of frameworks 37 and 38 using alkyne metathesis or cross 
coupling. 
 
Figure 1.15. Comparation of BET surface areas of frameworks 37-AM, 37-CC, 38-AM and 38-
CC synthesized using reversible alkyne metathesis or irreversible cross coupling at different 
temperatures.  
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1.3. Conclusion and Perspectives. 
Alkyne metathesis has only been studied intensively recently. Great efforts have been 
invested in design of high activity, broadening functional groups tolerance and user friendly 
catalysts. Also living alkyne polymerization has achieved great success recently although it is 
quite monomer-dependent. It has been used in natural products, conjugated polymer synthesis. 
By utilizing the dynamic feature of metathesis, the synthetic difficulty of well-defined 2-D 
macrocycles and 3-D cage molecules were dramatically decreased. The reversibility was proved 
to be an important factor to synthesize more ordered structures and improve the BET surface 
areas of covalent organic frameworks. The rigidity and stability of alkyne bond helps resisting 
the collapse of hollow molecules. Thus the 2-D and 3-D frameworks built from ethynylenes 
showed high surface areas.  
Well-defined 2-D, 3-D porous materials have potential applications in gas 
adsorption/separation, drug delivery, sensing, etc. Until now, only one paper of 3-D organic cage 
and one literature about 2-D and 3-D COFs synthesized through alkyne metathesis were reported. 
This area is still in its infant stage. Without the limitation of catalyst activity, scientists will be 
able to utilize alkyne metathesis to develop more 3-D organic architectures in the future.  
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CHAPTER 2 
 
 
 
Tetrameric Cage with an Unexpected D2h Symmetry through Alkyne Metathesis 
 
(Manuscript was submitted under the same title, co-authored with Zhang, C. X.; Noll, B. C.; 
Long, H.; Jin, Y., and Zhang, W.) 
2.1. Abstract 
Shape-persistent covalent organic polyhedrons (COPs) with ethynylene linkers are 
usually prepared through kinetically controlled cross-coupling reactions. Herein, we report high-
yielding synthesis of ethynylene-linked rigid tetrameric cages via one-step alkyne metathesis 
from readily accessible triyne precursors. The tetrameric cage contains two macrocyclic panels 
and exhibits unique D2h symmetry. The assembly of such a COP is a thermodynamically 
controlled process, which involves the initial formation of macrocycles as key intermediates 
followed by the connection of two macrocycles with ethynylene linkages. With a large internal 
cavity, the cage exhibits a high binding selectivity toward C70 (K = 3.9×103 L·mol-1) over C60 (no 
noticeable binding). 
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2.2. Introduction 
In recent years, discrete purely organic cage molecules, i.e. covalent organic polyhedrons 
(COPs) have attracted great attention due to their unique properties and interesting applications 
in gas adsorption/separation,1-5 host-guest recognition6-11 and as molecular “flasks”.12-13 
Moreover, their great potential in emerging applications such as catalysis and drug delivery is 
highly attractive. Recent advances in dynamic covalent chemistry (DCvC) have provided 
powerful thermodynamically controlled approaches towards COPs.14-18 Most COPs reported so 
far are assembled through dynamic imine chemistry or boronic acid condensation.16,19-21 
Although these COPs have shown intriguing applications in chemistry and materials science, 
imine or B-O linkages are susceptible to hydrolysis in the presence of acid, base or even 
moisture,22-23 which leads to the decomposition of COPs and represents a potential drawback for 
certain applications. In this regard, COPs with more robust ethynylene linkages have attracted 
our attention. Besides the rigidity and high chemical and thermal stability, ethynylene linkages 
can enable electron conjugation if needed, which would be a valuable feature for electrical, 
optical, and sensing applications. To date, ethynylene-linked COPs have generally been prepared 
through Sonogashira, or Glaser-type coupling.24-31 As coupling reactions are kinetically 
controlled, the target molecular cages are oftentimes obtained in low yields along with a large 
amount of oligomeric or polymeric side products. High-dilution (or pseudo high dilution) 
conditions with a large excess of catalysts are usually applied to minimize the “over-shooting” 
problem, however, with limited success. Alternatively, templates have been used to preorganize 
the monomers and direct the syntheses of nanorings or rotaxanes and cantenanes.32-35 Herein, we 
report template-free, dynamic covalent assembly of a purely hydrocarbon molecular cage 
through one-step alkyne metathesis.  The tetrameric cage consists of two macrocyclic panels and 
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exhibits an unexpected D2h symmetry. With a large internal cavity, the cage molecule serves as a 
fullerene receptor and shows a high binding selectivity for C70 over C60.  
2.3. Results and discussion 
Alkyne metathesis36-39 has emerged as an alternative viable dynamic covalent reaction.  It 
has been widely practiced in the synthesis of natural products,37,40 shape-persistent 
macrocycles,41-44 and polymers.45-50  However, only recently has alkyne metathesis been applied 
to more challenging COP synthesis which involves innumerable possible oligomeric and 
polymeric intermediates along the pathway to the target COP.  In 2011, we reported the first 
application of dynamic alkyne metathesis in the synthesis of an ethynylene-linked shape-
persistent rectangular prism.10 In our previous study, (benzoyldiphenyl)acetylene moiety had to 
be installed in the monomer unit to drive the equilibrium to the cage product by precipitation of 
bis(benzoylbiphenyl)acetylene byproducts. However, installation of the precipitating groups in 
the monomer requires additional synthetic steps, and their poor solubility causes difficult 
monomer purification and premature precipitation of oligomeric intermediates. Recently, we 
have developed triphenolsilane-based alkyne metathesis catalysts that are compatible with 5 Å 
molecular sieves, scavengers of small alkyne byproducts, e.g. 2-butyne.44 In the presence of 
molecular sieves, simple propynyl substituted monomers can undergo alkyne metathesis with 
high conversion in a closed system using triphenolsilane-based catalysts. Therefore, in this study, 
simple triyne 41a and 41b are designed as the monomers of the tetrahedron-shaped tetrameric 
COP 42Td (Figure 2.1a). Compounds 41a and 41b are C3-symmetric with an edge-face angle of 
60.0° which closely matches the edge-face angle of a tetrahedron (54.7°).  The syntheses of 41a 
and 41b are straightforward starting from readily available acetyl benzene 39a and 39b. SiCl4 
catalyzed condensation reaction followed by Negishi coupling afforded 41a and 41b in good 
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NMR spectrum of the tetramer showed splitting of each set of originally chemically equivalent 
protons of the monomer unit into two signals in 2:1 ratio (total eight sets of aromatic proton 
signals, Figure 2.3i).  This is inconsistent with the expected highly symmetrical tetrahedral 
structure 42Td (Figure 2.1a), which should show only four sets of aromatic proton signals.  We 
excluded the possibility of two dimeric cages being interlocked, since (1) the dimeric cage of 41a 
(or 41b) would be highly strained and disfavored; (2) we did not observe any dimer species in 
the MALDI-MS; (3) The 1H NMR spectra of the cage product at various temperatures 
consistently show sharp and distinct signals rather than broad and complicated ones. The 
tetrameric cage 42D2h (Figure 2.1b) with D2h symmetry was then proposed, in which two 
macrocycle panels are connected by two diphenylacetylene side arms. This structure gives rise to 
the splitting of the three arms of a monomer into two types: two identical arms forming the 
macrocyclic panel with another monomer and a third arm bridging two macrocycles to form a 
cage. This agrees with the observed 2:1 ratio of two signals for each set of originally chemically 
equivalent protons of the monomer unit in 1H NMR spectra of 42D2h-A4 and 42D2h-B4.   
The structure 42D2h was unambiguously determined by single crystal X-ray diffraction 
(Figure 2.2).  Needle-like single crystals of 42D2h-A4 were obtained through slow evaporation 
from a solution of 42D2h-A4 in CH2Cl2 and acetonitrile co-solvent.  42D2h-A4 was crystallized in 
the monoclinic space group P121/c1. It has been a challenge to obtain crystal structures of pure 
hydrocarbon cages due to their sensitivity to solvent loss and the easy collapse of the crystals.24  
After multiple failed trials, we finally succeeded in determining the structure and packing of the 
cage 42D2h-A4 albeit with weak X-ray diffraction. The two macrocyclic panels (top and bottom 
of the cage) are slightly puckered and oriented in a slipped stack fashion relative to each other 
with the distance of 9.1 Å between them (Figure 2.2a, 2.2c).  Two biphenyl acetylene arms 
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bridge the two panels with the face-to-edge angle of 49.4°, resulting in overall Z-shape geometry 
of the cage (Figure 2.2b). The dimension of the cage interior at the widest point is 19.4 Å.  The 
packing structure shows that there are two stacks of parallel cages that are arranged at an angle 
of 141.7° to each other (Figure 2.2d, 2.2f).  There is no connectivity between the cavities of the 
cages.  The interior cavity of each cage is filled with one disordered acetonitrile molecule, and 
two propyl groups from the two neighboring cages.  We did not observe any inter/intramolecular 
π-π interactions.  Due to the absence of functional groups with directing capability, the van der 
Waals interactions between neighboring molecules and C-H•••π interactions between propyl 
chain and aromatic moieties appear to be the major forces to direct the crystal packing of the 
cage.  This represents one of few purely hydrocarbon cage crystal structures. 
 
Figure 2.2. Crystal structure of 42D2h-A4: (a) Side view 1; (b) Side view 2; (c) Top view; (d) 
Crystal packing views along (011) direction; (e) Simplified view of 42D2h-A4; (f) Simplified 
view of the crystal packing, the two stacks of the cages oriented differently are color coded in 
yellow and magenta.  Solvent molecules are omitted for clarification. 
 
49.4 
(a) (b) (c)
19.4 Å
9.1 Å
(d) (e) (f)
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Figure 2.3. 1H NMR spectra of monomer 41a (a); Authentic sample of macrocyclic intermediate 
43 (b); crude mixture after 0.5-4 h (c-h); cage product 42D2h-A4 (i), in CDCl3. 
The formation of tetramer 42D2h-A4 is quite unexpected.  In order to gain better 
understanding of the cage formation process, we monitored the reaction progress.  Aliquots of 
the reaction mixture were withdrawn at different time intervals, and analyzed by GPC and 1H 
NMR spectroscopy. The GPC traces showed the initial formation of high molecular weight 
oligomers and their gradual conversion to 42D2h-A4 (Figure 2.10). A closer look at the process 
through 1H NMR data analysis revealed the initial conversion of monomer 3a to a substantial 
amount of macrocycle 6 within 0.5 h (Figure 3). The authentic sample of macrocycle 6 was 
obtained by conducting alkyne metathesis of monomer 41a in a closed system in the absence of 
molecular sieves that are typically used to scavenge 2-butyne byproduct. After stirring at 55 oC 
for 1 h, macrocycle 6 was isolated in 22% yield, together with unreacted monomer 41a. This 
experiment supports the notion that the macrocycle 43 is present in a significant amount as a key 
intermediate during the formation of cage 42D2h-A4.  The formation of a tetramer with D2h 
symmetry is therefore likely guided by the initial predominant formation of macrocyclic panels 
(face-directed) rather than by the geometrical angle of the monomer arms (edge-directed).  
Intrigued by this observation, we attempted to prepare cage 42D2h (R = n-C7H15) through 
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kinetically controlled cross-coupling of two macrocyclic building blocks 45 and 46 (Scheme 2.2). 
Macrocycle 45 was obtained in excellent isolated yield (90%) through alkyne metathesis of 
compound 44. This indicates the formation of 45 is a thermodynamically favored process and no 
significant angle strain is involved, further supporting the possibility that macrocyclic species 43 
forms first and directs the assembly of 4D2h. Complementary macrocyclic building block 46 was 
then obtained via Sonogashira coupling of 8 with trimethylsilyl acetylene (TMSA) followed by 
desilylation.  Kinetically controlled cross-coupling reactions have played an important role in the 
construction of well-defined, 2-D and 3-D molecular architectures.43,51-52  However, the 
attempted cross coupling of 45 and 46 failed to yield cage 4D2h under our tested reaction 
conditions (details see experimental section). MALDI-TOF MS, GPC and 1H NMR analyses of 
the crude product mixtures in multiple trials showed the formation of oligomers and polymers 
without any noticeable amount of the cage products. More exotic reaction conditions that might 
lead to the desired cage formation were not further explored. 
 
Scheme 2.2. Synthesis of 42D2h via kinetic control. (I) cat. 3, CCl4, 55 oC, 90%; (II) 
trimethylsilylacetylene, Pd(PPh3)2Cl2, CuI, piperidine, THF, 80 oC; (III) K2CO3, MeOH, PhMe, 
4 h, r.t.; (IV) Sonogashira cross-coupling reactions under various conditions. 
In order to confirm that the cage 4D2h is a thermodynamically favored product and its 
formation is reversible, we conducted the scrambling experiment between 42D2h-A4 and 42D2h-
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B4. A 1:2 mixture of 42D2h-A4 and 42D2h-B4 were subjected to alkyne metathesis (55 oC, CCl4, 
16 h).  The GPC trace of the crude reaction mixture showed a new peak with a broad shoulder 
(Figure 2.4).  MALDI-MS of the crude reaction mixture showed all possible scrambled products, 
A3B, A2B2, AB3 together with A4 and B4, indicating that the system is dynamic and the cage 
42D2h is not kinetically trapped.   
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Figure 2.4. The GPC traces of the crude product from the cage scrambling experiment: 42D2h -
A4 (red); 42D2h -B4 (blue); the crude mixture (black). 
 The cage 43D2h -A4 has a large cavity with a distance between the top and bottom panels 
of ~9.0 Å based on the crystal structure. The shape-persistency and the rigid backbones 
consisting of aromatic moieties make cage 42D2h -A4 an attractive host for guest molecules, such 
as fullerenes. In order to investigate the host-guest binding interactions between 42D2h -A4 and 
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protons (He’) are shielded in the presence of the fullerene guest.  Analysis of the Job Plot (Figure 
2.23) shows 1:1 binding stoichiometry between C70 and the cage 42D2h-A4 with the binding 
constant of 3.9×103 mol-1. The energy-minimized structure of C70@42D2h-A4 shows that upon 
fullerene binding the bottom and top macrocyclic panels become perfectly co-facial rather than 
the original “slipped” conformation of the empty cage, with an enlarged interpanel distance 
about 11.7 Å (Figure 2.5b).  Based on the computer modeling, the binding energy of 42D2h-A4 
with C70 is 10 kcal/mol lower than that of binding with C60 (-48.7 vs. -38.4 kcal/mol).  
Presumably C70 is bigger and more ellipsoidal than C60, and resembles the shape of the cavity, 
thus providing a better fit inside the cage and stronger binding interaction.  
We also attempted to synthesize the cage 42D2h with bromo group and methyl groups 
instead of propyl groups. However the metathesis reaction was not successful, resulting mainly 
oligomers. We believe that the inefficiency is due to the poor solubility of monomers and 
oligomer intermediates. Thus during the reaction, oligomers may precipitate out which cannot be 
further converted to desired cage product.  
In conclusion, tetrameric cages 42D2h with an uncommon D2h symmetry were obtained 
through one-step alkyne metathesis from readily accessible C3 symmetrical propynyl-substituted 
monomers in good yields.  The unexpected unique structure of the cage 42D2h-A4 was fully 
characterized by 1D 1H, and 13C NMR, gCOSY, ROESY, GPC, MALDI-TOF MS and single 
crystal X-ray diffraction. The formation of the cage is likely a face-directed dynamic assembly 
process, which involves the formation of dimeric macrocycle panels as the key intermediates. 
Our attempts to synthesize the cage 42D2h through cross-coupling of two macrocyclic building 
blocks under various reaction conditions failed, showing that a dynamic covalent approach could 
be advantageous compared to kinetically controlled approaches for constructing complex 
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molecular architectures.  Finally, the cage 42D2h-A4 shows selective binding interactions for C70 
(Kassoc=3.9×103 mol-1) over C60 (no noticeable binding).   
2.4. Experimental Section 
2.4.1. Materials and general synthetic methods  
Reagents and solvents were purchased from commercial suppliers and used without 
further purification, unless otherwise indicated. Tetrahydrofuran (THF), toluene, CH2Cl2 and 
dimethylformamide (DMF) were purified by the MBRAUN solvent purification systems.  
All reactions were conducted under dry nitrogen in oven-dried glassware, unless 
otherwise specified. All the alkyne metathesis reactions were conducted in glovebox. The 
solvents used in alkyne metathesis were dried over 4 Å molecular sieves. Solvents were 
evaporated using a rotary evaporator after workup. Unless otherwise specified, the purity of the 
compounds was 1 95 % based on 1H NMR spectral integration. 
Flash column chromatography was performed by using a 100-150 times weight excess of 
flash silica gel 32-6γ ȝm from Dynamic Absorbants Inc. Fractions were analyzed by TLC using 
TLC silica gel Fβ54 β50 ȝm precoated-plates from Dynamic Absorbants Inc. Analytical gel 
permeation chromatography (GPC) was performed using a Viscotek GPCmaxTM, a Viscotek 
Model 3580 Differential Refractive Index (RI) Detector, a Viscotek Model 3210 UV/VIS 
Detector and a set of two Viscotek Viscogel columns (7.8 × 30 cm, l-MBLMW-3078, and l-
MBMMW-3078 columns) with THF as the eluent at 30 °C. The analytical GPC was calibrated 
using monodisperse polystyrene standards. UV-vis absorption measurements were carried out 
with Agilent 8453 spectrophotometer. 
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MALDI-TOF Mass spectra were obtained on the Voyager-DE™ STR Biospectrometry 
Workstation using sinapic acid (SA) as the matrix. The high resolution mass spectra were 
obtained on Waters SYNAPT G2 High Definition Mass Spectrometry System. Analyte 
molecules were diluted into ESI solvents, methanol, chloroform or acetonitrile/water mixture, for 
final concentrations of 10 ppm or lower.  The solution was injected into the electrospray 
ionization (ESI) source at a rate of 5 L/min. Either the ESI+ or ESI− mode was used in 
reference to the molecular properties. Accurate mass analysis was performed by using the Lock 
Mass calibration feature with the instrument.   
NMR spectra were taken on Inova 400 and Inova 500 spectrometers. CHCl3 (7.27 ppm), 
toluene-d8 (2.09 ppm) were used as internal references in 1H NMR, and CHCl3 (77.00 ppm) for 
13C NMR.  1H NMR data were reported in order: chemical shift, multiplicity (s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet), coupling constants (J, Hz), number of protons. 
2.4.2. Synthetic procedures 
Reaction scheme: 
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1-(3-Bromo-5-iodophenyl)ethanone: The reported procedure in the literature was followed.53 3-
Bromo-5-iodobenzoic acid (7.00 g, 21.4 mmol) and oxalyl chloride (5.4 g, 42.8 mmol) were 
dissolved in dry dichloromethane (35 mL) and the mixture was cooled to 0 oC. Then DMF (70 
L) was added to the reaction mixture and the reaction was allowed to warm up to room 
temperature slowly.  After stirring for overnight, all the solvent was removed under vacuum and 
the product was directly subjected to the next step without further purification. CuCN (2.55 g, 
28.5 mmol) and LiCl (2.41 g, 56.9 mmol) were added to a Schlenk tube, followed by THF (50 
mL). The mixture was stirred for 10 min to form a clear solution. The resulting solution was 
cooled at -78 oC and a solution of CH3MgCl in THF (3 M, 9.5 mL) was added slowly. The 
solution was allowed to warm up to -30 oC and stirred for 5 min before it was cooled to -78 oC 
again. A solution of the above acid chloride in THF (50 mL) was added to the above solution at -
78 oC. The mixture was allowed to warm up to -20 oC and stirred at -20 oC overnight. The 
reaction mixture was poured into a mixture of saturated aqueous NH4Cl (140 mL) and 
concentrated NH3·H2O (28 mL). The organic layer was extracted with EtOAc (2 x 140 mL) and 
the combined organic extracts were washed with brine (130 mL). After removing the volatiles, 
the residue was purified by flash column chromatography (eluting with hexane/CH2Cl2, 3/1, v/v) 
to provide the pure product as a white solid (5.21 g, 75% in two steps): 1H NMR (500 MHz, 
CDCl3) δ 8.1λ (t, J = 1.5 Hz, 1H), 8.05 (t, J = 1.7 Hz, 1H), 8.04 (t, J = 1.6 Hz, 1H), 2.58 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 1λ5.17, 143.78, 139.75, 135.94, 130.71, 123.46, 94.62, 26.58. 
HRMS (m/z): [M]+ calcd. for C8H6BrIO, 323.8647; found, 323.8651. 
1-(3-Bromo-5-propynylphenyl)ethanone: The typical procedure for Sonogashira cross 
coupling reaction was followed.54 To a Schlenck tube, 1-(3-bromo-5-iodophenyl)ethanone (2.0 g, 
6.15 mmol), Pd(PPh3)2Cl2 (129 mg, 0.18 mmol), and CuI (12 mg, 0.06 mmol) were added. After 
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vac/refill with N2 three times, toluene (20 mL) and TEA (20 mL) were added into the reaction 
flask. Then the mixture was cooled to -20oC~-30oC and propyne was bubbled into the solution 
for 10 min. The reaction was sealed, and the cooling bath was removed. The mixture was stirred 
at r.t. for 4 h. The reaction flask was opened slowly to release the pressure. The volatiles were 
removed and CH2Cl2 (50 mL) was added. After washing the reaction mixture with brine (70 mL) 
and satd. NH4Cl (70 mL), the organic layer was dried over anhydrous Na2SO4. The solvent was 
removed under reduced pressure and the residue was purified by flash column chromatography 
(eluting with 10% CH2Cl2 in hexane) to provide the pure product as a white solid (1.33 g, 91%): 
1H NMR (400 MHz, CDCl3) δ 7.91 – 7.87 (m, 1H), 7.80 – 7.76 (m, 1H), 7.63 – 7.59 (m, 1H), 
2.52 (s, 3H), 2.01 (s, 3H);  13C NMR (101 MHz, CDCl3) δ 1λ5.86, 1γ8.βγ, 1γ8.10, 1γ0.01, 
129.95, 126.35, 122.43, 88.71, 77.50, 26.49, 4.23; HRMS (m/z): [M]+ calcd. for C9H11BrO, 
235.9837; found, 235.9832.
 
Compound 39a: To a round bottom flask, 1-(3-bromo-5-propynylphenyl)ethanone (4.00 g, 16.9 
mmol) and Pd/C (5%) (3.6 g, 1.69 mmol) were added. After vac/refill with N2 three times, 
EtOAc (30 mL) was added. After purging with H2 three times, the reaction was stirred under H2 
(balloon) at r.t. for 3 h. The reaction was monitored by 1H NMR spectroscopy. After all the 
starting material was consumed, the volatiles were removed and the residue was dissolved in 
EtOAc (40 mL). The solids were filtered and the solvent was removed. The crude product was 
purified by flash column chromatography (eluting with 10% CH2Cl2 in hexane) to give pure 39a 
(3.50 g, 88%): 1H NMR (500 MHz, CDCl3) δ 7.λ0 (t, J = 1.7 Hz, 1H), 7.69 (t, J = 1.4 Hz, 1H), 
7.53 (t, J = 1.7 Hz, 1H), 2.63 (t, J = 7.7 Hz, 2H), 2.59 (s, 3H), 1.72 – 1.61 (m, 2H), 0.95 (t, J = 
7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 1λ6.8γ, 145.γβ, 1γ8.64, 1γ5.8λ, 1β8.80, 1β6.8λ, 
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122.59, 37.47, 26.62, 24.22, 13.60; HRMS (m/z): [M]+ calcd. for C11H13BrO, 241.0310; found, 
241.0317. 
Compound 40a: To a Schlenck tube, compound 39a (800 mg, 3.35 mmol) was added.  Under 
nitrogen flow, EtOH (absolute, 20 mL) was added to the reaction flask. The reaction mixture was 
cooled at 0 oC, and SiCl4 (4.44 mL, 33.5 mmol) was added dropwise to the reaction. The ice bath 
was removed and the reaction was stirred at r.t. overnight. A lot of precipitates were formed. The 
reaction mixture was poured into ice water (100 mL). The product was extracted with CH2Cl2 (3 
x 50 mL). The organic extracts were combined and the volatiles were removed. The residue was 
purified by flash column chromatography (eluting with 10 % CHCl3 in hexane) to give pure 
compound 40a (655 mg, 88%):1H NMR (500 MHz, CDCl3) δ 7.67 (s, γH), 7.6γ (t, J = 1.7 Hz, 
3H), 7.40 – 7.38 (m, 3H), 7.38 – 7.37 (m, 3H), 2.67 (t, J = 7.7 Hz, 6H), 1.76 – 1.66 (m, 6H), 0.99 
(t, J = 7.4 Hz, 9H); 13C NMR (101 MHz, CDCl3) δ 145.4λ, 14β.65, 141.γ6, 1γ0.68, 1β7.67, 
126.34, 125.50, 122.79, 37.79, 24.48, 13.80. MALDI-TOF(m/z): [M+Li]+ calcd. for C33H33Br3Li, 
675.0266; found, 675.0159.  
Compound 41a: To a Schlenk tube, propynyllithium (165 mg, 3.57 mmol), ZnBr2 (743 mg, 3.29 
mmol) and THF (4 mL) were added under nitrogen. After stirring for 30 min at r.t., a solution of 
the compound 40a (400 mg, 0.60 mmol) and Pd(PPh3)4 (103 mg, 0.090 mmol) in THF (4 mL) 
was added to the mixture. The mixture was stirred at 70 oC overnight, and the solvent was 
removed under reduced pressure. The residue was redissolved in CH2Cl2 (25 mL), and the 
solution was washed with brine (60 mL). The organic layer was dried over anhydrous Na2SO4 
and concentrated under vacuum. The residue was purified by flash column chromatography 
(eluting with hexane/CH2Cl2, 15/1, v/v) to give pure compound 41a (200 mg, 61%): 1H NMR 
(500 MHz, CDCl3) δ 7.78 (s, 3H), 7.61 (s, 3H), 7.45 (s, 3H), 7.30 (s, 3H), 2.69 (t, J = 7.7 Hz, 
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6H), 2.12 (s, 9H), 1.80 – 1.69 (m, 6H), 1.02 (t, J = 7.4 Hz, 9H); 13C NMR (101 MHz, CDCl3) δ 
143.18, 141.73, 140.91, 130.61, 127.74, 126.92, 125.02, 124.24, 85.61, 79.89, 37.81, 24.45, 
13.77, 4.23. HRMS (m/z): [M]+ calcd. for C42H42, 546.3287; found, 546.3282. 
 
42D2h-A4: The monomer 41a (800 mg, 1.65 mmol), 5 Å molecular sieves (4.0 g), and CCl4 (58 
mL) were added to a Schlenk tube in glovebox. In an separate flask, the multidentate ligand Lsi 
(17.λ mg, 0.04λ mmol) and the Mo(VI) carbyne precursor Et≡Mo[NAr(tBu)]3 (29 mg, 0.049 
mmol) were mixed in dry CCl4 (2 mL) and the mixture was stirred for 10 minutes to generate the 
catalyst in situ. The catalyst solution was added to the above monomer solution and the mixture 
was stirred at 55 oC in a closed system.  The reaction was monitored by GPC and 1H NMR. After 
stirring for 16 h, the molecular sieves were filtered and the filtrate was concentrated. The residue 
was dissolved in THF (7 mL) and the solution was added to MeOH (70 mL) dropwise while 
stirring. A white precipitate formed immediately upon the addition. The precipitate was collected 
and washed with MeOH (2 × 50 mL) to provide pure cage 42D2h-A4 (561 mg, 82 %): 1H NMR 
(500 MHz, CDCl3) δ 7.λλ (s, 4H), 7.λ6 (s, 8H), 7.75 (s, 8H), 7.6γ (s, 4H), 7.55 (s, 4H), 7.5γ (s, 
8H), 7.47 (s, 4H), 7.45 (s, 8H), 2.80 (t, J = 7.6 Hz, 8H), 2.74 (t, J = 7.6 Hz, 16H), 1.89 – 1.75 (m, 
24H), 1.14 – 1.03 (m, 36H); 13C NMR (75 MHz, CDCl3) δ 14γ.4β, 14γ.γ8, 14β.4β, 141.λ8, 
141.62, 141.07, 130.15, 129.84, 129.82, 129.43, 127.67, 127.21, 125.73, 125.29, 123.58, 123.51, 
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89.88, 89.55, 38.00, 24.60, 24.49, 13.92, 13.89; MALDI-TOF(m/z): [M+H]+ calcd. for C144H133, 
1863.04; found: 1862.96. 
 
The cage 42D2h-B4 was synthesized following the similar procedure as cage 42D2h-A4.  
Compound 39b: To a seal tube, after vacuum and refill with N2 three times, the 1-tetradecene 
(906 mg, 4.62 mmol) and THF (3 mL) were added under N2. The solution was cooled in ice bath 
and 9-BBN (9.3 mL, 0.5M in THF) was added dropwise and the mixture was stirred for 10 min 
before removing ice bath. After stirring at room temperature for 4 h, to the above solution were 
added Pd(dppf)Cl2 (112 mg, 0.154 mmol), 1-(3-Bromo-5-iodophenyl)ethanone (1.00 g, 3.08 
mmol), K2CO3 (1.70 g, 12.3 mmol) in DMF (3 mL). The reaction was heated to 40 oC for 
overnight. The reaction was monitored by NMR. After the starting materials were fully 
converted, the solvent was removed under rotavap. The residue was redissolved in EtOAc (20 
mL) and washed with brine (50 mL × 2) and the organic layer was dried over Na2SO4. After 
concentrated, the residue was purified by flash chromatography (eluting with 1% EtOAc in 
hexanes). Prodcut (912 mg, 88%) was collected. 1H NMR (500 MHz, CDCl3)μ δ 7.8λ (t, J = 1.8 
Hz, 1H), 7.69 (s, 1H), 7.53 (t, J = 1.8 Hz, 1H), 2.67 – 2.61 (m, 2H), 2.59 (s, 3H), 1.66 – 1.56 (m, 
  - 43 - 
 
2H), 1.37 – 1.20 (m, 22H), 0.88 (t, J = 6.9 Hz, 3H). 13C NMR (101 MHz, CDCl3)μ δ 1λ7.0λ, 
145.89, 138.89, 136.12, 129.04, 127.10, 122.88, 35.80, 32.17, 31.45, 29.94, 29.93, 29.90, 29.88, 
29.88, 29.78, 29.66, 29.62, 29.42, 26.92, 22.95, 14.38. 
The physical data of Compound 40b: 1H NMR (500 MHz, CDCl3)μ δ 7.67 (s, γH), 7.6γ (t, J = 
1.8 Hz, 3H), 7.39 (s, 3H), 7.38 (t, J = 1.7 Hz, 3H), 2.72 – 2.65 (m, 6H), 1.72 – 1.60 (m, 6H), 1.43 
– 1.20 (m, 66H), 0.88 (t, J = 6.9 Hz, 9H). 13C NMR (101 MHz, CDCl3)μ δ 146.0γ, 14β.λ0, 141.61, 
130.87, 127.87, 126.53, 125.74, 123.07, 36.07, 32.19, 31.67, 29.96, 29.95, 29.93, 29.92, 29.85, 
29.74, 29.63, 29.58, 22.96, 14.41. 
The physical data of Compound 41b: 1H NMR (400 MHz, CDCl3)μ δ 7.70 (s, γH), 7.53 (s, 3H), 
7.37 (d, J = 1.7 Hz, 3H), 7.23 (s, 3H), 2.68 – 2.58 (m, 6H), 2.07 (s, 9H), 1.64 (p, J = 7.4 Hz, 6H), 
1.23 (s, 66H), 0.86 (t, J = 6.7 Hz, 9H). 
The physical data of cage 42D2h-B4: 1H NMR (500 MHz, CDCl3) δ 7.λ4 (s, 4H), 7.λ0 (s, 8H), 
7.69 (s, 8H), 7.56 (s, 4H), 7.49 (s, 4H), 7.48 (s, 8H), 7.42 (s, 4H), 7.40 (s, 8H), 2.77 (t, J = 7.9 Hz, 
8H), 2.71 (t, J = 7.9 Hz, 16H), 1.85 – 1.66 (m, 24H), 1.50 – 1.21 (m, 264H), 0.91 – 0.85 (m, 
36H); 13C NMR (101 MHz, CDCl3) δ 14γ.68, 14γ.64, 141.λλ, 141.6β, 141.05, 130.04, 129.75, 
129.40, 127.60, 127.14, 125.72, 125.51, 125.28, 123.60, 123.56, 89.88, 89.55, 35.98, 31.95, 
31.61, 31.58, 31.43, 29.74, 29.69, 29.67, 29.62, 29.56, 29.44, 29.40, 22.72, 14.15. MALDI-
TOF(m/z): [M+H]+ calcd. for C276H397, 3714.11; found: 3714.22. 
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Macrocycle 43: To a solution of monomer 41a (20 mg, 0.036 mmol) in CCl4 (5 mL) was added a 
newly generated catalyst solution (1 mL, generated from the precursor 2.4 mg, 0.0036 mmol and 
the ligand 1.5 mg, 0.0036 mmol as described above). The reaction mixture was stirred at 55 oC 
for 1 h. The reaction was quenched by the addition of MeOH (1 mL). After removing the 
volatiles, the residue was purified by flash column chromatography (eluting with hexane/CH2Cl2, 
10/1~7/1, v/v). The macrocycle 43 (4 mg, 22%) was obtained together with unreacted monomer 
41a. The physical data of macrocycle 43: 1H NMR (400 MHz, CDCl3) δ 8.05 (s, βH), 8.00 (s, 
4H), 7.79 (d, J = 1.6 Hz, 4H), 7.57 (s, 2H), 7.54 (t, J = 1.7 Hz, 4H), 7.41 (q, J = 1.4 Hz, 6H), 
7.26 (t, J = 1.6 Hz, 2H), 2.70 (t, J = 7.7 Hz, 8H), 2.65 (t, J = 7.7 Hz, 4H), 2.09 (s, 6H), 1.72 (m, 
12H), 0.98 (m, 18H). 13C NMR (101 MHz, CDCl3) δ 14γ.57, 14γ.γγ, 14β.14, 141.γ0, 141.14, 
140.56, 130.82, 130.17, 129.08, 127.18, 125.23, 124.81, 124.19, 123.59, 89.74, 85.73, 79.91, 
77.32, 77.00, 76.68, 38.01, 29.71, 24.56, 13.93; MALDI-TOF(m/z): [M+H]+ calcd. for C76H72, 
985.57; found: 986.83. 
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Compound 47 was synthesized following the similar synthetic route as 40a. 1H NMR (500 MHz, 
Chloroform-d)μ δ 7.6γ (s, γH), 7.γλ (s, γH), 7.γ7 (s, γH), β.7γ – 2.63 (m, 6H), 1.72 – 1.63 (m, 
6H), 1.44 – 1.21 (m, 24H), 0.89 (t, J = 6.8 Hz, 9H). 
Compound 48 was synthesized following the reported procedures.10 
The physical data of Compound 49: 1H NMR (500 MHz, CDCl3)μ δ 7.λ8 (t, J = 1.8 Hz, 1H), 
7.87 (t, J = 1.5 Hz, 1H), 7.72 (t, J = 1.7 Hz, 1H), 2.59 (s, 3H), 2.42 (t, J = 7.1 Hz, 2H), 1.66 – 
1.58 (m, 2H), 1.49 – 1.34 (m, 4H), 0.94 (t, J = 7.2 Hz, 3H). 
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The physical data of Compound 39c: 1H NMR (500 MHz, CDCl3)μ δ 7.8λ (s, 1H), 7.6λ (s, 1H), 
7.53 (s, 1H), 2.69 – 2.62 (m, 2H), 2.59 (d, J = 0.8 Hz, 3H), 1.67 – 1.60 (m, 2H), 1.38 – 1.23 (m, 
8H), 0.89 (t, J = 7.0 Hz, 3H). 
Compound 44: To a Schlenk tube, compound 47 (200 mg, 0.239 mmol), (148 mg, 
0.52 mmol), Pd(PPh3)2Cl2 (11.7 mg, 0.017 mmol) and CuI (1.2 mg, 0.013 mmol) were added. 
After vac/refill with N2 three times, THF (2 mL) and piperidine (0.6 mL) were added. The 
reaction system was evacuated and refilled with N2 three times. The mixture was stirred at 60 oC 
for 13 h. The solvent was removed under reduced pressure, and the residue was purified by flash 
column chromatography (eluting with hexane/CH2Cl2, 1/1~1/2.5, v/v) to give compound 44 (96 
mg, 33%): 1H NMR (500 MHz, CDCl3) δ 7.λβ (d, J = 8.3 Hz, 4H), 7.87 – 7.82 (m, 5H), 7.76 (d, 
J = 1.6 Hz, 2H), 7.76 – 7.72 (m, 6H), 7.72 – 7.66 (m, 9H), 7.65 – 7.60 (m, 2H), 7.56 – 7.49 (m, 
6H), 7.48 – 7.44 (m, 3H), 7.39 (t, J = 1.6 Hz, 1H), 2.74 (t, J = 7.8 Hz, 4H), 2.70 (d, J = 7.8 Hz, 
2H), 1.77 – 1.65 (m, 6H), 1.47 – 1.26 (m, 24H), 0.93 – 0.87 (m, 9H). 13C NMR (101 MHz, 
CDCl3) δ 1λ6.1λ, 145.7γ, 144.β0, 14γ.λ0, 14β.88, 141.87, 141.β4, 141.07, 1γλ.58, 1γ7.61, 
136.46, 132.41, 132.21, 130.83, 130.77, 130.51, 129.97, 128.30, 127.90, 127.86, 127.63, 127.18, 
126.79, 126.31, 125.58, 125.32, 123.46, 123.13, 122.77, 90.85, 89.01, 35.90, 35.81, 31.80, 31.77, 
31.48, 31.41, 29.32, 29.27, 29.18, 29.13, 22.67, 22.64, 14.11, 14.09. MALDI-TOF(m/z): [M+H]+ 
calcd. for C87H84BrO2, 1239.56; found, 1239.46. 
Compound 45: To a Schlenk tube, compound 44 (44 mg, 0.0355 mmol) and CCl4 (1 mL) were 
added. In a separate flask, the multidentate ligand Lsi (1.0 mg, 0.0025 mmol) and the Mo(VI) 
alkylidyne precursor Et≡Mo[NAr(tBu)]3 (1.6 mg, 0.025 mmol) were mixed in dry CCl4 (1 mL) 
and the mixture was stirred for 10 minutes to generate the catalyst in situ.  The catalyst solution 
was added to the above solution of compound 44. The mixture was stirred at 55 oC in a closed 
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system for 1 h. A white precipitate was formed during the reaction. The white solid was filtered, 
and the filtrate was concentrated. The residue was purified by flash column chromatography 
(eluting with hexane/CH2Cl2, 10/1, v/v) to give compound 45 (22.4 mg, 90 %): 1H NMR (500 
MHz, CDCl3) δ 8.0λ (s, βH), 8.01 (s, 4H), 7.78 (d, J = 1.6 Hz, 4H), 7.69 (s, 2H), 7.56 (s, 4H), 
7.44 (s, 6H), 7.39 (s, 2H), 2.75 (t, J = 7.8 Hz, 8H), 2.70 (d, J = 7.8 Hz, 4H), 1.79 – 1.66 (m, 12H), 
1.46 – 1.28 (m, 48H), 0.92 – 0.88 (m, 18H). 13C NMR (101 MHz, CDClγ) δ 145.70, 14γ.λβ, 
143.21, 141.40, 141.28, 140.43, 130.46, 130.11, 129.09, 127.73, 127.01, 126.41, 125.55, 124.69, 
123.65, 122.73, 89.76, 36.00, 35.81, 31.81, 31.78, 31.49, 31.40, 29.34, 29.27, 29.20, 29.14, 22.68, 
22.66, 14.12, 14.10. MALDI-TOF(m/z): [M+H]+ calcd. for C94H114Br2, 1402.73; found: 1402.58. 
Compound 46: To a Schlenk tube, compound 45 (30.5 mg, 0.0217 mmol), Pd(PPh3)2Cl2 (1.6 mg, 
0.0022 mmol) and CuI (0.2 mg, 0.0022 mmol) were added. After vac/refill with N2 three times, 
THF (0.5 mL), trimethylsilylacetylene (0.02 mL, 0.13 mmol) and piperidine (0.2 mL) were 
added. After vac/refill with N2 three times, the reaction mixture was stirred at 80 oC for 16 h. The 
solvent was removed under reduced pressure, and the residue was purified by flash column 
chromatography (eluting with hexane/CH2Cl2, 15/1, v/v). The isolated product was dissolved in 
toluene (1 mL) and MeOH (1 mL), and K2CO3 (29 mg) was added.  The reaction was stirred at 
r.t. for 4 h before the solvent was removed under reduced pressure. The residue was redissolved 
in CH2Cl2 (15 mL) and washed with brine (30 mL). After drying over Na2SO4, the solvent was 
removed and the crude was purified by flash column chromatography (eluting with 
hexane/CH2Cl2, 20/1, v/v) to give compound 46 (26 mg, 93% for two steps):  1H NMR (500 
MHz, CDCl3) δ 8.0λ (t, J = 1.7 Hz, 2H), 8.02 (t, J = 1.6 Hz, 4H), 7.81 (d, J = 1.7 Hz, 4H), 7.70 (t, 
J = 1.6 Hz, 2H), 7.56 (t, J = 1.6 Hz, 4H), 7.52 (t, J = 1.7 Hz, 2H), 7.44 (t, J = 1.4 Hz, 4H), 7.39 (t, 
J = 1.5 Hz, 2H), 3.15 (s, 2H), 2.81 – 2.67 (m, 12H), 1.80 – 1.65 (m, 12H), 1.46 – 1.23 (m, 48H), 
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0.94 – 0.87 (m, 18H). 13C NMR (101 MHz, CDCl3) δ 14γ.λ0, 14γ.80, 141.84, 141.47, 141.23, 
140.51, 131.24, 130.07, 129.09, 128.51, 128.38, 127.03, 125.37, 124.71, 123.63, 122.33, 89.76, 
83.91, 36.01, 35.82, 31.81, 31.79, 31.50, 31.42, 29.35, 29.28, 29.20, 29.16, 22.68, 22.66, 14.12, 
14.10.  
2.4.3. Attempted synthesis of 42D2h through cross-coupling reactions  
 
General Procedure: To a Schlenk tube, compound 45 and 46 in 1:1 molar ratio, Pd(PPh3)4, and 
CuI were added. After vac/refill with N2 three times, the solvent (THF or toluene) and 
triethylamine (TEA) were added. After vac/refill with N2 three times, the reaction mixture was 
stirred at 90~110 oC for 16~40 h. The reaction progress was monitored using TLC, NMR, GPC 
and MALDI-TOF MS.  
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Compound 41c: To a seal tube, starting materials 1-(3-Bromo-5-propynylphenyl)ethanone (200 
mg, 0.843 mmol) was added and vac/refill with N2 for 3 times. Then EtOH (2.0 mL, absolute) 
was added and the reaction mixture was cooled at 0 oC. The SiCl4 (860 mg, 2.53 mmol) was 
added dropwise. After addition, the ice bath was removed and the reaction was stirred at room 
temperature for overnight. To workup this reaction, the reaction mixture was poured into cold 
water and extracted with CH2Cl2 (50 mL) for 3 times. After concentration of the organic phase, 
the residue was purified by column chromatography (eluting with hexanes/ CH2Cl2, 20/1). 
Product (129 mg, 70%) was collected. 1H NMR (500 MHz, CDCl3) δ 7.7β (s, γH), 7.6λ (s, γH), 
7.63 (s, 3H), 7.58 (s, 3H), 2.10 (s, 9H). 
 
Compound 41d: To a seal tube, starting materials 41c (15 mg, 0.0228 mmol) was added. After 
vac/refill 3 times with N2, THF (1 mL) was added to the flask and cooled to -78 oC. n-BuLi 
(0.080 mmol) was added dropwise. The reaction mixture was stirred for 50 min at -78 oC. Then 
CH3I (13 L, 0.205 mmol) was added to the reaction mixture at -78 oC. Then the reaction was 
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allowed to slowly warm up to room temperature for overnight. The reaction was quenched by 
water and extracted with CH2Cl2 (50 mL × 3) and purified by column chromatography 
(hexanese/CH2Cl2, 8/1~7/1). Product (11 mg, 100%) was isolated out. 1H NMR (400 MHz, C6D6) 
δ 7.67 (s, 3H), 7.49 (s, 3H), 7.35 (s, 3H), 7.18 (s, 3H), 2.35 (s, 9H), 2.03 (s, 9H). 13C NMR (101 
MHz, C6D6) δ 141.54, 140.8γ, 1γ8.γ4, 1γ1.11, 1β7.41, 1β4.λβ, 1β4.β0, 85.66, 7λ.66, β1.βγ, 4.β8. 
Table 2.1. The attempted synthesis of 42D2h through cross coupling reactions under various 
conditions. 
Entry 
Amount 
of 
Monomer 
45 (mmol) 
Solvent TEA Pd(PPh3)4 
mol% Temperature 
Reaction 
Time 
1 0.004 THF (5 mL) 5 mL 10  90 oC 40 h 
2 0.005 THF (3.5 mL) 3.5 mL 20  90 oC 18 h 
3 0.005 THF (2.5 mL) 2.5 mL 10  90 oC 18 h 
4 0.005 toluene (10 mL) 10 equiv. 10  110 oC 16 h 
  5* 0.005 toluene(10 mL) 110 equiv. 20  110 oC 20 h 
* More TEA (100 e.q.) and palladium catalyst (10 %) were added to the reaction mixture of 
entry 4 and stirred for another 20 h after 16 h reaction of entry 4. 
 
2.4.4. Scrambling experiment 
Cage 42D2h-A4 (2.0 mg, 0.0011 mmol) and cage 42D2h-B4 (8.0 mg, 0.0022 mmol) and a 
solution of catalyst 3 (generated from precursor 0.39 mg, 0.00058 mmol; ligand 0.23 mg, 
0.00058 mmol as described above) in CCl4 (0.5 mL) were added to a dry Schlenk tube in 
glovebox. The reaction was stirred at 55 oC for 16 h. 
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2.4.5. Characterization of 4D2h-A4 
  
Figure 2.6. The 1H NMR spectrum of cage 42D2h-A4 in toluene-d8. 
 
Figure 2.7. The aromatic region of gCOSY spectrum of cage 42D2h-A4 in toluene-d8. 

  - 53 - 
 
2.4.6. GPC data of the kinetic study 
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Figure 2.10. Kinetic study of the cage 42D2h-A4 formation through alkyne metathesis: GPC 
traces of a crude product mixture after 0.5 h, 1.0 h, 1.5 h, 2.0 h, 3.0 h, 4.0 h, 5.75 h of the 
reaction time and the monomer 41a. The GPC data showed the reaction was completed after 4 
hours.  The catalyst loading was 3 mol% per propynyl group. 
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Figure 2.11. GPC traces of the crude reaction mixture of the macrocycle 43 formation (red), 
isolated macrocycle 43 (black), the monomer 41a (magenta), and the cage 42D2h-A4 (blue). 
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2.4.7. The binding study of cage 42D2h-A4 with fullerene 
 
Figure 2.22. a) The structure of 42D2h-A4 with the assigned proton peaks based on 1H NMR, 
gCOSY and ROESY. b) The 1H NMR spectrum of 42D2h -A4 in toluene-d8. 
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Figure 2.23. The Job Plot for the binding of C70 with cage 42D2h-A4, showing that the binding 
of C70 and cage 42D2h-A4 is in 1:1 stoichiometry. The chemical shift changes of proton Ha’ were 
used for the calculation. 
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Figure 2.24. The 1H NMR titration data of (a) cage 42D2h-A4 (0.13 mM) with various amount of 
C60 (0-6.2 equiv), and (b) cage 42D2h-A4 (0.14 mM) with various amount of C70 (0-8.6 equiv). 
The 1H NMR titrations were done in toluene-d8.  
 
 
 
 
 
 
(a)
HbHcHĐ’Hď’HdHd’Ha’Ha He’ He
(b)
HbHcHĐ’Hď’HdHd’Ha’Ha He’ He
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2.4.8. Crystal structure report 
A specimen of C155.20H149.80Cl4N4.60, approximate dimensions 0.032 mm x 0.117 mm 
x 0.159 mm, was used for the X-ray crystallographic analysis. The X-ray intensity data were 
measured on a Bruker D8 VENTURE diffractometer system equipped with a multilayer mirror 
monochromator and a Cu Kα microfocus sealed tube (Ȝ = 1.54178 Å). The XRD data of 42D2h-
A4 was deposited at Cambridge Crystallographic Data Centre with DDCD number 999558. 
Table 2.2: Data collection details for 42D2h-A4.
Axis dx/mm 2θ/° ω/° φ/° χ/° Width/
° 
Frame
s 
Time/
s 
Wavelengt
h/Å 
Voltag
e/kV 
Current/m
A 
Temperature
/K 
Omega 34.975 90.68 346.95 45.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Phi 34.975 90.68 0.28 198.00 23.00 0.50 632 45.00 1.54184 50 1.0 130 
Phi 34.974 75.68 77.65 0.00 -44.37 0.50 720 45.00 1.54184 50 1.0 130 
Omega 34.974 -15.73 342.19 0.00 -61.50 0.50 147 20.00 1.54184 50 1.0 130 
Omega 34.974 90.68 346.95 90.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Phi 34.974 90.68 90.39 0.00 -23.00 0.50 720 45.00 1.54184 50 1.0 130 
Omega 34.974 90.68 346.95 180.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Omega 34.974 -45.68 213.62 360.00 44.87 0.50 198 30.00 1.54184 50 1.0 130 
Phi 34.974 90.68 92.65 0.00 -44.38 0.50 720 45.00 1.54184 50 1.0 130 
Omega 34.974 90.68 346.95 135.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Omega 34.974 -30.68 228.62 90.00 44.87 0.50 198 45.00 1.54184 50 1.0 130 
Omega 34.974 -45.68 213.62 90.00 44.87 0.50 198 30.00 1.54184 50 1.0 130 
Omega 34.974 90.68 346.95 225.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Omega 34.975 90.68 93.47 135.0 -44.87 0.50 194 45.00 1.54184 50 1.0 130 
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Axis dx/mm 2θ/° ω/° φ/° χ/° Width/
° 
Frame
s 
Time/
s 
Wavelengt
h/Å 
Voltag
e/kV 
Current/m
A 
Temperature
/K 
0 
Omega 34.975 -60.68 198.62 0.00 44.87 0.50 198 45.00 1.54184 50 1.0 130 
Omega 34.975 90.68 346.95 270.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Omega 34.975 -60.68 198.62 90.00 44.87 0.50 198 45.00 1.54184 50 1.0 130 
Omega 34.975 90.68 346.95 315.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
Omega 34.975 90.68 93.47 45.00 -44.87 0.50 194 45.00 1.54184 50 1.0 130 
Omega 34.975 -15.73 244.57 144.00 44.87 0.50 194 20.00 1.54184 50 1.0 130 
Omega 34.975 90.68 346.95 0.00 61.50 0.50 211 45.00 1.54184 50 1.0 130 
 
A total of 6199 frames were collected. The total exposure time was 73.47 hours. The 
frames were integrated with the Bruker SAINT software package using a narrow-frame 
algorithm. The integration of the data using amonoclinic unit cell yielded a total 
of 112997 reflections to a maximum θ angle of 50.43° (1.00 Å resolution), of which 6998 were 
independent (average redundancy 16.147, completeness = 99.8%, Rint = 7.16%, Rsig =2.23%) 
and 5827 (83.27%) were greater than βσ(F2). No significant diffraction was observed beyond 1 Å, 
even with exposures of 120 s/°. The final cell constants 
of a = 16.4702(12) Å, b = 11.9661(8) Å, c = γ4.01λ(β)Å, ȕ = 91.009(3)°, volume = 6703.6(8) Å3, 
are based upon the refinement of the XYZ-centroids of 9962 reflections above β0 σ(I) with 5.199° 
< βθ < 108.6°. Data were corrected for absorption effects using the multi-scan method 
(SADABS). The ratio of minimum to maximum apparent transmission was 0.934. The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.8340 and 0.9630. 
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The structure was solved and refined using the Bruker SHELXTL Software Package, 
using the space group P121/c1, with Z= 2 for the formula unit, C155.20H149.80Cl4N4.60 (Figure 
2.25). The final anisotropic full-matrix least-squares refinement on F2 with 765 variables 
converged at R1 = 11.39%, for the observed data and wR2 = 38.15% for all data. The goodness-
of-fit was 1.785. The largest peak in the final difference electron density synthesis was 1.234 e-
/Å3 and the largest hole was -1.128 e-/Å3 with an RMS deviation of 0.121 e-/Å3. On the basis of 
the final model, the calculated density was 1.100 g/cm3 and F(000), 2362 e-. 
 The asymmetric unit, figure 2.26, contains ½-molecule of the cage compound, 2.3 
molecules of acetonitrile, and 1 molecule of dichloromethane. The complete structure is 
generated by inversion. During refinement, Fobs2 was observed to be consistently greater than 
Fcalc2. The data were examined for indications of nonmeroheral twinning, and, although a few 
small, unindexed reflections exist, there is not strong evidence to support this idea (see Figure 
2.27). Inspection for a pseudomerohedral twin was also unsuccessful. With such a large cavity in 
the center of the cage structure, it is possible that there is some randomly oriented solvent within 
the structure that might account for the observation, Fobs2 >> Fcalc. Because of this unresolved 
electron density, the model is incomplete, and the agreement factors R1 and wR2 remain high. In 
addition, a suitable weighting scheme could not be calculated. The weight used for refinement 
was 0.2. The full SHEXL-2013 results file and all intensity data, formatted for SHELXL-2013, 
are appended to the CIF file.  
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Figure 2.25. Image of complete structure after symmetry applied. H atoms omitted for clarity. 
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Figure 2.26. Image of asymmetric unit. H atoms omitted for clarity. 
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Figure 2.27. Generated precession image for layer hk1. There is little evidence for 
nonmeroehdral twinning. 
 
 
 
Table 2.3. Sample and crystal data for 42D2h-A4.
Identification code CU_IX57 
Chemical formula C155.20H149.80Cl4N4.60 
Formula weight 2221.19 
Temperature 130(2) K 
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Wavelength 1.54178 Å 
Crystal size 0.032 x 0.117 x 0.159 mm 
Crystal system monoclinic 
Space group P 1 21/c 1 
Unit cell dimensions a = 16.4702(12) Å α = λ0° 
 
b = 11.9661(8) Å ȕ = λ1.00λ(γ)° 
 
c = 34.019(2) Å Ȗ = λ0° 
Volume 6703.6(8) Å3 
 
Z 2 
Density (calculated) 1.100 g/cm3 
Absorption coefficient 1.188 mm-1 
F(000) 2362 
 
 
42D2h-A4
Diffractometer Bruker D8 VENTURE diffractometer 
Radiation source microfocus sealed tube, Cu Kα 
Theta range for data collection 2.60 to 50.43° 
Index ranges -16<=h<=16, -11<=k<=11, -34<=l<=34 
Reflections collected 112997 
Independent reflections 6998 [R(int) = 0.0716] 
Coverage of independent reflections 99.8% 
Absorption correction multi-scan 
Max. and min. transmission 0.9630 and 0.8340 
Structure solution technique direct methods 
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Structure solution program SHELXT v2014/1 (Sheldrcik, 2014) 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-2014 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 6998 / 48 / 765 
Goodness-of-fit on F2 1.785 
Final R indices 5827 data; I>βσ(I) R1 = 0.1139, wR2 = 0.3684 
 
all data R1 = 0.1265, wR2 = 0.3815 
Weighting scheme w=1/[σ2(Fo2)+(0.2000P)2] 
where P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 1.234 and -1.128 eÅ-3 
R.M.S. deviation from mean 0.121 eÅ-3 
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CHAPTER 3 
 
 
A Covalent Organic Polyhedron (COP) with an Unexpected Dumbbell Shape Constructed 
Through One-Step Alkyne Metathesis 
 
3.1. Abstract 
A well-defined 3-D organic cage molecule, with a unique dumbbell shape, was 
synthesized via one-step alkyne metathesis from readily accessible precursors in high yield. The 
unexpected formation of the tetrameric cage rather than the originally expected dimeric cage 
clearly shows the great importance of avoiding high angle strain in the design and synthesis of 
shape-persistent molecular cages via thermodynamically controlled alkyne metathesis reaction. 
The obtained cage molecule exhibits binding interactions with fullerenes, which opens the 
possibility for future development of novel cage-fullerene nanohybrid materials through self-
assembly process. 
3.2. Introduction 
In recent years, discrete three-dimensional (3-D) covalent organic polyhedrons (COPs) 
have attracted great attention due to their unique properties and wide applications. With intrinsic 
porosity, shape-persistent 3-D cage compounds have been studied in gas adsorption, gas 
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separation (e.g., CO2/N2 or CO2/CH4 separation) 1-3, guest recognition 4-7 and as reaction “flasks” 
8-11
. Moreover, their great potential in newly explored applications such as catalysis and drug 
delivery is highly attractive.  
Supramolecular 3-D cages constructed via metal-ligand coordination have been well 
studied over the past few decades. 12-13 By using certain metal ions and rigid organic ligands, well 
defined shape-persistent 3-D structures were efficiently assembled with designed geometry and 
functionality.4-6 In great contrast, covalent cage molecules, such as COPs with high thermal and 
chemical stability have rarely been reported in contrast to those supramolecular ones, which is 
mainly due to their great synthetic difficulty. Since the covalent bond formation is usually 
“irreversible” and does not have the “self-correction” mechanism, the desired products are 
usually synthesized in multiple steps with kinetic control and in low overall yields. To overcome 
such kinetic barriers and enable efficient synthesis of well-defined covalent organic molecular 
structures, dynamic covalent chemistry (DCC) has been developed as a thermodynamically 
controlled approach allowing the construction of 2-D and 3-D molecular architectures from 
simpler precursors in one step and high yield. With reversible formation of covalent bonds, the 
thermodynamically most stable product will be predominantly formed.  
Currently the most commonly used dynamic covalent reaction is imine 
condensation/metathesis.1-2,14-17 Other DCvC such as condensation reactions of boronic acids and 
diols have also been reported.18-20  Although these reactions have shown a variety of applications 
in chemistry and materials science, the sensitivity of the imine or borate groups to acid or 
moisture represents a potential drawback for certain applications. It has been demonstrated that 
reduction of imine groups to amines can significantly increase the product stability, but the 
molecule generally loses some rigidity and conjugation, which sometimes are highly desired 
  - 69 - 
 
properties. On the other hand, olefin metathesis and alkyne metathesis represent alternative 
DCvC reactions, and they have been successfully utilized to construct shape-persistent 2-D 
macrocycles with high chemical and thermal stability.21  However, construction of well-defined 
3-D cage molecules through olefin or alkyne metathesis has rarely been explored. Given the 
rigidity and linear geometry of acetylene bonds, we envisioned that alkyne metathesis would be 
an alternative viable approach for the synthesis of robust shape-persistent COPs. Moreover, the 
conjugated acetylene linkers render the cage potential in electrical, optical, and sensing 
applications. Very recently, our group has successfully synthesized a porphyrin-based 3-D COP 
in high yield through alkyne metathesis which, for the first time, demonstrated the feasibility of 
constructing 3-D architectures by using this type of DCvC.22 Another ethynylene linked 
tetrameric COP was synthesized very recently, which exhibits a unique D2h symmetry. (The 
results were discussed in Chapter 2 and the manuscript was submitted.) In this work, we report 
the alkyne metathesis of a tricarbazolyl-substituted benzene monomer that led to the formation of 
a unique, unexpected tetrameric cage molecule, which showed the critical role of angle strain in 
determining the shape-persistent COP formation. Such knowledge would guide future rational 
design and synthesis of 3-D shape-persistent COPs via alkyne metathesis. 
3.3. Results and discussion 
Our original goal of this work is to construct a 3-D shape-persistent COP with a small 
pore size through alkyne metathesis, and we proposed the tricarbazolyl-substituted benzene 
would be the smallest monomer that can be utilized. The monomer synthesis starts with the 
alkylation of carbazole, followed by iodination and Sonogashira cross-coupling, affording mono-
substituted iodocarbazole 51a. After converting the iodo group to pinacol borate, followed by 
Suzuki coupling with 1,3,5-tribromobenzene, tri-armed monomer 53a was obtained, which was 
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expected dimer structure. To rule out the possibility that the species we isolated contains a 
mixture of two compounds, a gCOSY experiment was conducted (Figure 3.8). The spectrum 
clearly showed that the two peaks corresponding to the protons on the central benzenes are 
coupled to each other, which indicated these two sets of signals are indeed from one compound. 
Since the MALDI-MS showed the formation of a tetrameric cage, there are three possible 
product structures with different topology:1) a tetrahedron-shaped tetrameric cage, 2) a 
tetrameric cage containing two interlocked dimer cages, or 3) a tetrameric cage consisting of two 
dimer cages covalently connected to each other side by side, with a “dumbbell” shape (Figure 
3.3). In order to rule out the possibility that two sets of signals resulted from conformational 
locked structure on the NMR time scale, a high temperature (59 oC) NMR was conducted (Figure 
3.11). The spectrum showed only a little shift and relatively sharper peaks, without observing 
coalescence, which means that these two sets of peaks are indeed from different structural 
isomers (with different bond connections). Since a tetrahedral cage (Figure 3.3, 54C-a) should 
only exhibit one set of proton signals on the NMR spectrum due to its high symmetry, which is 
inconsistent with our experimental observation, 16 the possibility of formation of a tetrahedral 
cage can be ruled out. Given the observed two sets of proton signals on the 1H NMR spectrum, 
two of six bicarbazolylacetylene arms are likely in different chemical environment from the 
other four. Both the interlocked cage (Figure 3.3, 54B-a) and dumbbell-shaped cage (Figure 3.3, 
54D-a) have two different sets of protons (1:2 ratio) in their structures. However, non-covalently 
interlocked dimers are known to usually give much broader and more complex proton peaks than 
a single non-interlocked molecule and high temperature NMR should show peak coalescence 
because of higher exchange rate at higher temperature. 17 Therefore, the formation of the 
interlocked cage can be ruled out, and the isolated tetrameric cage compound was finally 
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assigned to the dumbbell-shape structure 54D-a (Figure 3.4), in which the bond connection can 
be considered as follows: a cage dimer is formed first with two arms covalently connected, then 
the unreacted two acetylene end groups point outside and are covalently connected with the two 
acetylene groups of the other dimer to form the final tetrameric cage. In such configuration, the 
two inside “bridging” arms are in different chemical environment from the other four outside, 
which also causes the asymmetry of the protons on the four benzene rings.  
 
Figure 3.1. The MALDI-MS of the crude reaction mixture from the metathesis of monomer 53a. 
 
Figure 3.2. Expanded aromatic region of 1H NMR of cage 54D-a in C6D6.  The label of each 
peak is consistent with the label on Figure 3.5. Assignment is based on gCOSY, ROESY and 
NOESY experiments (Figure 3.11-3.13). 
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conjugated to achieve a large π-surface area. In contrast, on the inner two arms, in order to avoid 
the steric hindrance between hydrogens on the 2, 4-position on carbazole and those on the phenyl 
groups, the carbazoles and central benzenes cannot be in the same plane. Also the 
bicarbazolylacetylene arm is a little bit twisted to minimize the distance to the other arm. Such 
close proximity may offer some favored π-π interaction between those two arms to gain further 
stabilization. The computer calculation indicates that a significant angle strain is built up upon 
the covalent bonding of the third arm in the dimer case. Since the angle between the two 
substitutions of a carbazole (3 & 6 positions, acetylene group & central benzene) is not perfect 
90o (calcd. 87.4o), in spite of small angle difference away from the desired one, the third arm in a 
very rigid dimer cage could suffer significant strain. Thus it is conceivable that the first two 
dicarbazolylacetylene arms in the dimer cage can be formed relatively easily. However the 
unreacted third acetylene end groups left on both sides of the dimer cannot easily take the 
favored conformation to get the third arm covalently connected through metathesis, and they just 
point outside to minimize the steric hindrance. Finally, two unclosed dimers get close to each 
other and react to form the two bridging arms, thus affording the final tetrameric cage structure. 
  The formation of such an unexpected, unique dumbbell-shaped tetrameric cage instead 
of the originally expected dimeric one clearly demonstrates the critical role of angle strain in 
determining the product distribution. To enable the predominant formation of certain shape-
persistent molecular cages via reversible alkyne metathesis, the target structures should be the 
thermodynamically most favored and have minimal angle strain, which represents an important 
criterion for rational design of 2-D and 3-D shape-persistent molecular architectures. 
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Figure 3.5. Calculated molecular modeling structure of cage 54D, top view (a) and side view (b), 
54D@C60(c), 54D@C70(d). Methyl groups were used in the calculation instead of alkyl chains 
for simplicity. 
To further understand the reaction process, a kinetic study was conducted. Aliquots of the 
reaction mixture were withdrawn at different time intervals, and analyzed by GPC, MALDI and 
1H NMR spectroscopy. The GPC traces showed the initial formation of high molecular weight 
oligomers and their gradual conversion to cage 54D-a (Figure 3.6.a). The precipitation driven 
reaction was very fast. Only after 5 min, the reaction already gave a large amount of oligomers 
(Figure 3.6.a), and the cage formation completed after 2 h and 10 min. Based on MALDI-TOF 
MS, the dimeric macrocyclic intermediate was observed clearly in the first 5 min of the reaction 
(Figure 3.6.b). 
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Figure 3.6. a) Kinetic study of the cage 54D-a formation through alkyne metathesis: GPC traces 
of a crude product mixture after 5 min, 10 min, 15 min, 20 min, 25 min, 30 min, 35 min and 130 
min of the reaction time. The GPC data showed the reaction was completed after 2 hours and 10 
min. b) MALDI-TOF MS of the crude reaction mixture of 5 min. The m/z peak 3097.7 is 
corresponding to the dimeric macrocycle intermediate. 
Since the tetrameric cage 54D has two open ends (bowl-shape) exhibiting a fully 
conjugated π-surface and the carbazole is known as a good electron donor moiety, we next 
studied the binding interaction of this cage with fullerene electron acceptors, C60 and C70. The 1H 
NMR titration was performed in both CS2 and toluene-d8. The shift of proton signals was 
observed in both solvents, which clearly indicates the binding interaction of the cage with 
fullerenes. It was also found that the binding affinity of the cage with a given fullerene in the 
good solvent CS2 is weaker than that in the poor solvent toluene, which is consistent with the 
previously reported case.23 NMR titration shows that the peaks of the protons on the outer 
carbazoles shift more significantly than other protons on the inner carbazoles (Figure 3.7). This 
indicates the fullerene binding sites of cage 54D are on the two bowl-shaped ends rather than the 
bridging arms, which is consistent with the computational simulation result (Figure 3.5, c&d).  
Unfortunately, given the poor solubility of fullerenes and the relatively weak binding interactions, 
the binding constants cannot be calculated. However, the shift of the proton signals for the C70-
bound cage was larger than that for the C60-bound cage, given the same equivalent loading of C70 
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Therefore later, long linear chains and branched alkyl chains were used. Unfortunately, the single 
crystal was not successfully obtained.  
We also designed a series of monomers with cleavable side chains. Their potential 
applications, besides tuning the solubility, are that the free carbazole sites can be further 
functionalized with other functional groups for different purposes, such as attaching active 
groups for growing frameworks, attaching specific molecular recognition sites for specific target 
binding. The carbamate groups are able to be cleaved under basic/acidic conditions. The 
synthesis of the monomers was straight forward. However, during the synthesis of cage 54D, it 
was found that the reactions of monomers with carbamate groups were much slower than the 
cage synthesis with alkyl chains, always resulting in oligomers based on GPC data. We believe 
that the electron withdrawing groups, e.g. carbamate group, likely decrease the electron density 
of the ethynylenes, thus slowing down the reaction of alkyne metathesis. Very recently, by using 
the silane based alkyne metathesis catalyst 3, the boc-protected cage 54D-j was synthesized and 
isolated successfully. These observations also illustrate the importance of development of highly 
reactive catalysts.   
 
Figure 3.8. The cage 54D with different side chains. 
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3.4. Conclusion 
In conclusion, a shape-persistent COP with a dumbbell shape was obtained in one step 
from readily accessible monomers in high yield through alkyne metathesis. The unexpected 
unique cage structure was fully characterized by 1H/13C NMR, gCOSY, ROESY, GPC and 
MALDI-TOF mass spectrometry. The computer modeling study also supported that the 
dumbbell-shaped tetrameric cage was energetically favored, with -17.4 kcal/mol lower energy 
than the formation of two dimers. In addition, without purposely incorporating strong donor 
moieties, this cage compound showed binding interactions with electron poor guest molecules 
C60 and C70, which opens new possibilities for fabrication of cage-fullerene composite materials. 
Alkyne metathesis as a dynamic covalent chemistry represents a novel highly efficient synthetic 
approach to shape-persistent 3D architectures. But the target structure should be 
thermodynamically favored and has minimal angle strain, which should be taken into 
consideration in rational molecular design. It should also be noted that the shape, size and 
functionality of cage molecules could be easily tuned in a modular fashion by varying the 
building blocks to achieve novel physical (e.g., electrical, optical) properties or high selectivity 
in guest recognition. 
3.5. Experimental Section 
3.5.1. Materials and general synthetic methods  
Reagents and solvents were purchased from commercial suppliers and used without 
further purification, unless otherwise indicated. Tetrahydrofuran (THF), toluene, CH2Cl2 and 
dimethylformamide (DMF) were purified by the MBRAUN solvent purification systems.  
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All reactions were conducted under dry nitrogen in oven-dried glassware, unless 
otherwise specified. All the alkyne metathesis reactions were conducted in glovebox. The 
solvents used in alkyne metathesis were dried over 4 Å molecular sieves. Solvents were 
evaporated using a rotary evaporator after workup. Unless otherwise specified, the purity of the 
compounds was 1 95 % based on 1H NMR spectral integration. 
Flash column chromatography was performed by using a 100-150 times weight excess of 
flash silica gel 32-6γ ȝm from Dynamic Absorbants Inc. Fractions were analyzed by TLC using 
TLC silica gel Fβ54 β50 ȝm precoated-plates from Dynamic Absorbants Inc. Analytical gel 
permeation chromatography (GPC) was performed using a Viscotek GPCmaxTM, a Viscotek 
Model 3580 Differential Refractive Index (RI) Detector, a Viscotek Model 3210 UV/VIS 
Detector and a set of two Viscotek Viscogel columns (7.8 × 30 cm, l-MBLMW-3078, and l-
MBMMW-3078 columns) with THF as the eluent at 30 °C. The analytical GPC was calibrated 
using monodisperse polystyrene standards.  
MALDI-TOF Mass spectra were obtained on the Voyager-DE™ STR Biospectrometry 
Workstation using sinapic acid (SA) as the matrix. The high resolution mass spectra were 
obtained on Waters SYNAPT G2 High Definition Mass Spectrometry System. Analyte 
molecules were diluted into ESI solvents, methanol, chloroform or acetonitrile/water mixture, for 
final concentrations of 10 ppm or lower.  The solution was injected into the electrospray 
ionization (ESI) source at a rate of 5 L/min. Either the ESI+ or ESI− mode was used in 
reference to the molecular properties. Accurate mass analysis was performed by using the Lock 
Mass calibration feature with the instrument.   
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NMR spectra were taken on Inova 400 and Inova 500 spectrometers. CHCl3 (7.27 ppm), 
toluene-d8 (2.09 ppm) were used as internal references in 1H NMR, and CHCl3 (77.00 ppm) for 
13C NMR.  1H NMR data were reported in order: chemical shift, multiplicity (s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet), coupling constants (J, Hz), number of protons. 
The Amber 11.0 molecular dynamics program package24 was used to optimize the 
structures of cages 54A, 54D and cage 54D@C60 and 54D@C70 by energy minimization for 
1000 steps. The force field used for the cages 54A, 54D and fullerenes was the general Amber 
force field (GAFF)25 with the charge parameters computed by the AM1-BCC method. 
3.5.2. Synthetic procedures 
  
9-hexadecyl-9H-carbazole (49a) and 9-hexadecyl-3,6-diiodo-9H-carbazole (50a) were made 
following reported procedure21. 
9-hexadecyl-9H-carbazole (49a): 1H NMR (500 MHz, CDCl3) δ 8.12 (d, J = 7.8 Hz, 2H), 7.48 
(dd, J = 8.0, 7.3 Hz, 2H), 7.42 (d, J = 8.1 Hz, 2H), 7.26 – 7.22 (m, 2H), 4.31 (t, J = 7.3 Hz, 2H), 
1.96 – 1.80 (m, 2H), 1.51 – 1.17 (m, 27H), 0.90 (t, J = 6.9 Hz, 3H).  
9-hexadecyl-3,6-diiodo-9H-carbazole (50a): 1H NMR (500 MHz, CDCl3) δ 8.34 (d, J = 1.6 Hz, 
2H), 7.72 (dd, J = 8.6, 1.7 Hz, 2H), 7.19 (d, J = 8.6 Hz, 2H), 4.23 (t, J = 7.2 Hz, 2H), 1.91 – 
1.70 (m, 2H), 1.45 – 1.14 (m, 27H), 0.89 (t, J = 7.0 Hz, 3H). 
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51a: To a Schlenk tube was added 9-hexadecyl-3,6-diiodo-9H-carbazole (50a) (2.028 g, 3.153 
mmol), 48 (1.00 g, 3.47 mmol), CuI (4.7 mg, 0.025mmol) and Ph(PPh3)2Cl2 (44 mg, 0.063 
mmol). Then the flask was degassed and refilled with N2 three times. With N2 bubbling, add 
THF (20 mL) and piperidine (10 mL) to the tube and degas and refill with N2 three time. After 
the mixture was reacted at room temperature overnight, it was washed with sat. NH4Cl. The 
aqueous layer was discarded. The organic layer was dried by Na2SO4 and the solvent was 
removed under reduced pressure. The reaction mixture was purified by column chromatography 
(with eluting solvent hexane/CH2Cl2, 1/8~1/2) and gave the light yellow solid 1.20 g (48%). 1H 
NMR (500 MHz, CDCl3) δ 8.40 (d, J = 1.6 Hz, 1H), 8.27 – 8.22 (m, 1H), 7.95 – 7.89 (m, 2H), 
7.86 (dt, J = 8.4, 1.6 Hz, 2H), 7.77 – 7.71 (m, 3H), 7.70 – 7.65 (m, 6H), 7.64 – 7.60 (m, 1H), 
7.56 – 7.50 (m, 2H), 7.36 (d, J = 8.5 Hz, 1H), 7.18 (d, J = 8.6 Hz, 1H), 4.24 (t, J = 7.1 Hz, 2H), 
1.94 – 1.73 (m, 2H), 1.48 – 1.14 (m, 27H), 0.90 (t, J = 8.9 Hz, 3H). 13C NMR (101 MHz, CDCl3) 
δ 196.5, 144.6, 140.3, 140.1, 139.3, 137.9, 136.6, 134.5, 132.7, 132.3, 131.1, 130.3, 130.1, 129.6, 
128.6, 127.4, 127.0, 125.1, 124.5, 124.0, 121.8, 113.9, 111.2, 109.2, 92.2, 87.9, 82.1, 43.5, 32.2, 
30.0, 29.9, 29.8, 29.7, 29.6, 29.1, 27.5, 23.0, 14.5. HRMS (ESI, m/z) calcd. for C49H52INO: 
797.3112, found: 797.3112. 
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52a: 51a (278 mg, 0.284 mmol) and Pd(PPh3)2Cl2 (7 mg, 0.01 mmol) were charged in a Schlenk 
tube. Then the tube was degassed and refill with N2 three times. With N2 bubbling, add toluene 
(5 mL) and TEA (1mL) to the tube and degas and refill three times and then add 4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (0.1 mL, 0.693 mmol). Then the mixture was heated to 85 oC 
overnight. After the mixture was cooled down to room temperature, it was washed with NH4Cl 
(sat., 50 mL) and dried over Na2SO4, then concentrated down. The reaction mixture was purified 
by column chromatography (with solvent hexane/CH2Cl2, 1/1~0/1) and gave 115 mg product 
(46%). 1H NMR (400 MHz, CDCl3) δ 8.63 (d, J = 10.7 Hz, 1H), 8.38 (s, 1H), 7.95 (t, J = 6.5 Hz, 
1H), 7.92 (d, J = 8.3 Hz, 2H), 7.85 (dd, J = 5.2, 3.4 Hz, 2H), 7.74 (d, J = 8.1 Hz, 2H), 7.71 – 
7.64 (m, 6H), 7.64-7.58 (m, 1H), 7.55-7.48 (m, 2H), 7.41 (d, J = 8.3 Hz, 1H), 7.38 (d, J = 8.5 Hz, 
1H), 4.29 (t, J = 6.9 Hz, 2H), 1.93 – 1.77 (m, 2H), 1.42 (s, 12H), 1.40 – 1.16 (m, 27H), 0.89 (t, J 
= 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 196.5, 144.7, 143.2, 140.5, 139.2, 137.9, 136.6, 
132.7, 132.6, 132.2, 131.0, 130.2, 129.5, 128.6, 128.2, 127.4, 127.0, 124.6, 124.2, 123.4, 122.4, 
113.7, 109.1, 108.6, 92.5, 87.6, 83.9, 43.5, 32.2, 30.0, 29.9, 29.8, 29.7, 29.6, 29.2, 27.5, 25.2, 
22.9, 14.4. HRMS (ESI, m/z) calcd for C55H64BNO3: 797.4991, found: 797.4991. 
  - 84 - 
 
 
53a: To a Schlenk tube was added 52a (290 mg, 0.363 mmol), 1,3,5-tribromobenzene (27.2 mg, 
0.0865 mmol), Na2CO3 (82.5 mg, 0.778 mmol) and Ph(PPh3)4 (10 mg, 0.0086 mmol). Then the 
flask was degassed and refill with N2 three times. With N2 bubbling, add toluene (10 mL), H2O 
(4mL) and EtOH (4 mL) to the tube and degas and refill three times. Then the mixture was 
heated to 85oC overnight. After the mixture was cooled down to room temperature, it was 
washed with sat. NH4Cl (50 mL). The aqueous layer was discarded. The organic layer was dried 
by Na2SO4 and the solvent was removed under reduced pressure. The reaction mixture was 
purified by column chromatography (with eluting solvent hexane/CH2Cl2, 1/1~1/4) and gave 115 
mg product (59%). 1H NMR (500 MHz, CDCl3) δ 8.56 (d, J = 1.5 Hz, 3H), 8.48 (d, J = 1.4 Hz, 
3H), 8.07 (s, 3H), 7.98 (dd, J = 8.5, 1.6 Hz, 3H), 7.89 – 7.84 (m, 6H), 7.84 – 7.80 (m, 6H), 7.71 
(dd, J = 8.4, 1.5 Hz, 3H), 7.70 – 7.64 (m, 12H), 7.63 – 7.59 (m, 9H), 7.56 (d, J = 8.6 Hz, 3H), 
7.53 – 7.48 (m, 6H), 7.44 (d, J = 8.5 Hz, 3H), 4.36 (t, J = 7.0 Hz, 6H), 1.98 – 1.88 (m, 6H), 1.49 
– 1.40 (m, 6H), 1.38-1.34 (m, 6H), 1.34 – 1.18 (m, 66H), 0.87 (t, J = 7.0 Hz, 9H). 13C NMR (101 
MHz, CDCl3) δ 196.4, 144.6, 143.3, 140.9, 140.7, 139.1, 137.9, 136.5, 133.3, 132.6, 132.2, 
131.0, 130.2, 129.7, 128.5, 127.4, 126.9, 126.2, 125.0, 124.6, 124.2, 123.3, 123.3, 119.5, 113.5, 
109.6, 109.2, 92.6, 87.7, 43.7, 32.1, 29.9, 29.8, 29.8, 29.7, 29.6, 29.3, 27.6, 22.9, 14.4. MALDI-
TOF MS: calcd. for C153H159O3N3: 2087.24, found: 2088.36 (MH+).  
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Cage 54D-a: The ligand LN (14.5 mg, 0.0303 mmol) and the molybdinium precursor (20.2 mg, 
0.0303 mmol) were premixed in dry carbon tetrachloride (1.5 mL) for 20 minutes to generate the 
catalyst in situ. Then the monomer 53a (115 mg, 0.055 mmol) was added and the stirring was 
continued overnight. The reaction was monitored by GPC. After GPC showed sharp single peak 
in reasonable rang, the reaction was taken out of the glovebox and the precipitates were filtered 
by vacuum filtration. The filtrate was concentrated down and purified by column 
chromatography (with eluting solvent hexane/CH2Cl2, 4/1) and 56 mg (79%) light yellow solid 
was collected. 1H NMR (500 MHz, CDCl3) δ 8.61 (s, 4H), 8.60 (s, 8H), 8.58(s, 4H),8.41(s, 8H), 
8.29(s, 4H), 8.11(s, 8H), 8.08(d, J=10 Hz, 8H),  7.98 (d, J=10Hz, 4H), 7.74 (d, J = 8.5, 8H), 7.66 
(d, J = 8.2, 8H), 7.57 (d, J = 8.6, 4H), 7.49 (d, J = 8.7 Hz, 8H), 7.45 (d, J = 8.7 Hz, 4H), 7.28 (d, 
4H), 4.40(s, 8H), 4.09(s, 16H), 1.98(m, 8H), 1.77(m, 16H), 1.27-1.15(m, 348H), 0.90-0.82(m, 
87H). 13C NMR (101 MHz, CDCl3) δ 143.0, 142.4, 140.4, 140.3, 133.1, 131.9, 129.7, 128.7, 
125.6, 125.2, 124.3, 124.0, 123.3, 123.2, 123.1, 122.8, 119.4, 118.5, 114.2, 114.0, 109.3, 109.1, 
108.7, 89.2, 88.0, 43.4, 43.1, 31.9, 29.7, 29.6, 29.5, 29.6, 29.1, 29.0, 27.4, 27.3, 22.7, 14.1. 
MALDI-TOF MS: calcd. for C372H480N12: 5115.79, found: 5115.66 (M+). 
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3.5.3. Host guest study of Cage 54D-a with Fullerenes in toluene-d8 and CS2 
 
A)
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Figure 3.9. NMR Titration study of cage 54D-a with C60 (A) and C70 (B) in toluene-d8. The 
concentration of cage 54D-a was 0.14 mmol/L. C) cage 54D-a with C60 and C70 in CS2. 
 
B)
C)
Cage 54D: C70 ~ 1:34
Cage 54D: C60 ~ 1:34
Cage 54D-a
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3.5.4. NMR characterization of cage 54D-a 
 
 
Figure 3.10. 1H NMR of cage 54D-a in C6D6 (A) and 13C NMR in CDCl3 (B). Proton b6 was 
hidden by benzene peak in 1H NMR. 
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Figure 3.12. ROESY of cage 54D-a in C6D6.  
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Figure 3.13. NOESY of cage 54D-a at room temperature in C6D6.  
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Figure 3.14. The aromatic region of 1H NMR of cage 54D-a at 20 oC (a) and 59 oC (b) in CDCl3.  
3.5.5. GPC characterization 
 
Figure 3.15. Normalized GPC traces of monomer 53 (black), crude reaction mixture after 
workup (red) and pure cage 54D-a (blue). 
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3.5.6. Synthetic procedures of 53b, 54D-c, 54D-d, 53h, 53g, 53i, 54D-j. 
 
Bis(1,1-dimethyltridecyl) dicarbonate was synthesized following literature procedure. 26 
3,6-diiodo-9H-carbazole was synthesized following literature procedure.27 To a solution of 
carbazole (20.0 g, 120 mmol) in acetic acid (500 mL) was added potassium iodide (25.8 g, 155 
mmol). With stirring, potassium iodate (33.8 g, 192 mmol) was slowly added to the mixture and 
refluxed for 15 min. The reaction mixture was cooled to room temperature, and then quenched 
with NaHSO3 (aq.) until the purple color disappeared. CH2Cl2 (200 mL) was added to the 
mixture. After separation, the organic layer was collected. The aqueous layer was washed with 
CH2Cl2 (100 mL × 2), and the organic layers were combined and washed with NaHCO3 (aq. 200 
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mL) and brine (150 mL). The organic phase was dried over Na2SO4 and the solvent was removed 
under vacuum. The product (31.0 g, 62%) was crystalized from CHCl3 (250 mL).   
52g were synthesized following similar procedure as 52a. 
Physical data for 50g:  1H NMR (500 MHz, CDCl3) δ 8.β1 (d, J = 1.7 Hz, 2H), 8.03 (d, J = 8.8 
Hz, 2H), 7.74 (dd, J = 8.8, 1.8 Hz, 2H), 2.08 – 2.02 (m, 2H), 1.72 (s, 6H), 1.51 – 1.20 (m, 20H), 
0.94 – 0.86 (m, 3H). 
Physical data for 51g:  1H NMR (500 MHz, CDCl3) δ 8.γ1 (d, J = 1.8 Hz, 1H), 8.27 (d, J = 8.6 
Hz, 1H), 8.13 (d, J = 1.5 Hz, 1H), 8.06 (d, J = 8.8 Hz, 1H), 7.93 (d, J = 8.3 Hz, 2H), 7.86 (dd, J 
= 8.3, 1.4 Hz, 2H), 7.79 – 7.72 (m, 3H), 7.72 – 7.66 (m, 5H), 7.65 – 7.60 (m, 1H), 7.53 (t, J = 
7.7 Hz, 2H), 2.11 – 2.02 (m, 2H), 1.74 (s, 6H), 1.53 – 1.19 (m, 20H), 0.88 (t, J = 7.0 Hz, 3H). 
Physical data for 52g:  1H NMR (400 MHz, CDCl3) δ 8.50 (d, J = 1.0 Hz, 1H), 8.29 (s, 1H), 8.26 
(s, 1H), 7.97 – 7.90 (m, 3H), 7.88 – 7.82 (m, 2H), 7.79 – 7.71 (m, 2H), 7.71 – 7.58 (m, 6H), 7.52 
(t, J = 7.3 Hz, 1H), 2.12 – 2.00 (m, 2H), 1.74 (d, J = 1.0 Hz, 6H), 1.55 – 1.18 (m, 32H), 0.87 (t, 
J = 6.8 Hz, 3H). 
Physical data for 53g:  1H NMR (400 MHz, CDCl3) δ 8.47 – 8.39 (m, 6H), 8.38 – 8.32 (m, 6H), 
8.07 (s, 3H), 7.98 – 7.93 (m, 3H), 7.90 – 7.78 (m, 12H), 7.75 – 7.57 (m, 24H), 7.55 – 7.46 (m, 
6H), 2.18 – 2.07 (m, 6H), 1.78 (s, 18H), 1.57 – 1.14 (m, 60H), 0.84 (t, J = 6.9 Hz, 9H). 
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9-Boc-3,6-diiodocarbazole (50j): To a round bottom flask, 3,6-diiodo-9H-carbazole (10.0 g, 
23.8 mmol), n 4-dimethylaminopyridine (2.66 g, 23.8 mmol) and di-tert-butyl dicarbonate (10.4 
g, 47.6 mmol) were dissolved in dry THF (300 mL). The reaction was stopped after stirring at r.t. 
for 3 h by removing all solvent under vacuum. The residue was redissolved in CH2Cl2 (200 mL) 
and washed with 1M HCl (150 mL), NaHCO3 (aq. 150 mL) and brine (150 mL) separately. Then 
the organic phase was concentrated down after dried over Na2SO4. The white product (11.4 g, 
92%) was collected after purified by column chromatography (hexanes/CH2Cl2, 2/1, v/v). The 
NMR characterization was the same as the reported.27 
Compound 51j: To a Schlenk tube 9-boc-3,6-diiodocarbazole (1.730 g, 3.33 mmol), compound 
48 (1.13 g, 4 mmol), Pd(PPh3)2Cl2 (70 mg, 0.1 mmol) and CuI (7 mg, 0.08 mmol) were charged. 
THF
 
(20 mL) and piperidine (7 mL) were added under N2 flow. The reaction was stirred at r.t. 
for 16 h. The solvent was removed by vacuum evaporation, the crude reaction mixture was 
dissolved in CH2Cl2 (50 mL) and washed with NH4Cl (sat., 70 mL) and brine (70 mL). The 
organic extracts were dried over Na2SO4, and concentrated. The residue was purified by flash 
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column chromatography (CH2Cl2/hexane, 1/1~1.5/1, v/v) to give the product as a yellow solid 
(1.05 g, 47 %).1H NMR (500 MHz, CDCl3) δ 8.βλ (d, J = 1.8 Hz, 1H), 8.27 (d, J = 8.7 Hz, 1H), 
8.11 (d, J = 1.8 Hz, 1H), 8.06 (d, J = 8.8 Hz, 1H), 7.92 (d, J = 8.2 Hz, 2H), 7.86 (d, J = 7.3 Hz, 
1H), 7.78 – 7.72 (m, 3H), 7.71 – 7.66 (m, 5H), 7.65 – 7.60 (m, 1H), 7.55 – 7.50 (m, 2H), 1.78 (s, 
9H). 13C NMR (126 MHz, CDCl3) δ 195.90, 150.20, 143.92, 139.15, 137.89, 137.76, 137.45, 
136.23, 135.69, 132.27, 131.99, 130.92, 130.64, 129.85, 128.40, 128.17, 127.05, 126.98, 126.56, 
124.13, 123.13, 122.88, 118.00, 117.73, 116.11, 90.79, 88.63, 86.79, 84.53, 28.18. 
1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene was synthesized following 
reported procedure.28 
53j is synthesized following the general Suzuki coupling procedure. 1H NMR (500 MHz, CDCl3) 
δ 8.47 – 8.41 (m, 6H), 8.40 – 8.33 (m, 6H), 8.08 (s, 3H), 7.97 (dd, J = 8.7, 1.9 Hz, 3H), 7.91 – 
7.79 (m, 12H), 7.76 – 7.57 (m, 24H), 7.55 – 7.48 (m, 6H), 1.83 (s, 27H). 
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3,6-Diiodo-9H-carbazole was synthesized following the reported procedure.29 
3,6-Diiodo-9-(2-ethyl)hexyloxycarbonyl-carbazole (50i) was synthesized following the 
modified synthetic procedure.30 1H NMR (500 MHz, CDCl3) δ 8.26 (d, J = 1.8 Hz, 2H), 8.07 (d, 
J = 8.8 Hz, 2H), 7.78 (dd, J = 8.8, 1.8 Hz, 2H), 4.54 – 4.43 (m, 2H), 1.86 (hept, J = 6.3 Hz, 1H), 
1.55 – 1.31 (m, 8H), 1.00 (t, J = 7.5 Hz, 3H), 0.93 (t, J = 7.0 Hz, 3H). 
51i and 53i were synthesized following similar procedure as synthesis of 51a and 53a. 
Physical data of 51i: 1H NMR (500 MHz, CDCl3) δ 8.β8 – 8.22 (m, 2H), 8.08 (t, J = 1.9 Hz, 1H), 
8.04 (d, J = 8.7 Hz, 1H), 7.95 – 7.90 (m, 2H), 7.88 – 7.83 (m, 2H), 7.77 – 7.71 (m, 3H), 7.70 – 
7.59 (m, 6H), 7.56 – 7.50 (m, 2H), 4.58 – 4.37 (m, 2H), 1.88 (hept, J = 6.3 Hz, 1H), 1.60 – 1.33 
(m, 8H), 1.02 (t, J = 7.5 Hz, 3H), 0.94 (t, J = 7.0 Hz, 3H). 
Physical data of 53i: 1H NMR (500 MHz, CDCl3) δ 8.47 (d, J = 8.7 Hz, 3H), 8.43 (d, J = 1.7 Hz, 
3H), 8.37 (d, J = 1.9 Hz, 6H), 8.08 (s, 3H), 7.98 (dd, J = 8.7, 1.9 Hz, 3H), 7.89 – 7.86 (m, 6H), 
7.84 – 7.81 (m, 6H), 7.74 (dd, J = 8.7, 1.7 Hz, 3H), 7.70 – 7.64 (m, 12H), 7.64 – 7.59 (m, 9H), 
7.51 (t, J = 7.7 Hz, 6H), 4.56 (dd, J = 5.7, 3.9 Hz, 6H), 1.94 (dt, J = 12.3, 6.0 Hz, 3H), 1.67 – 
1.57 (m, 6H), 1.41 (tt, J = 14.8, 7.5 Hz, 18H), 1.05 (t, J = 7.5 Hz, 9H), 0.95 (t, J = 7.1 Hz, 9H). 
13C NMR (101 MHz, CDCl3) δ 1λ6.γ5, 15β.50, 144.γ1, 14β.β8, 1γλ.47, 1γ8.48, 1γ8.γ5, 1γ7.8γ, 
136.60, 132.66, 132.35, 130.97, 130.21, 128.55, 127.34, 126.90, 126.10, 126.00, 123.59, 123.22, 
118.39, 118.16, 116.78, 116.48, 91.34, 88.95, 70.10, 39.17, 30.74, 29.17, 24.18, 23.28, 14.38, 
11.31.  
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Figure 3.16. The 1H NMR spectra of dilute (bottom) and concentrated (top) 53i, showing that 
the 53i has strong aggregation in solution. 
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53k: 53i (144 mg, 0.076 mmol) was dissolved in THF (3 mL). Then a NaOH (150 mg in 3 mL) 
solution was added. The mixture was heated to 75 oC overnight. Then the solvent was removed 
under reduced pressure. The resulting solids were washed with EtOAc (10 mL × 2) and hexanes 
(10 mL × 2). Then the solids (101 mg, 93 %) were collected as pure product. 1H NMR (500 MHz, 
THF-d8) δ 8.7λ (d, J = 1.7 Hz, 3H), 8.58 (d, J = 1.4 Hz, 3H), 8.23 (s, 3H), 8.07 (dd, J = 8.4, 1.8 
Hz, 3H), 7.90 (d, J = 8.3 Hz, 6H), 7.88 – 7.81 (m, 12H), 7.78 (d, J = 8.3 Hz, 6H), 7.71 (d, J = 
8.3 Hz, 6H), 7.69 – 7.63 (m, 9H), 7.59 – 7.53 (m, 9H). 
 
Figure 3.17. The 1H NMR of chain cleaved 53k. 
53b, 53c, and 53e were synthesized following general procedure for attaching bromo-alkane to 
carbazole. The yield of synthesizing 53d is low, mainly due to steric hinderance. Thus elevated 
temperature 65 oC is needed. 
Physical data of 53b 1H NMR (500 MHz, CDCl3) δ 8.57 (d, J = 1.7 Hz, 3H), 8.49 (d, J = 1.5 Hz, 
3H), 8.07 (s, 3H), 7.99 (dd, J = 8.5, 1.8 Hz, 3H), 7.90 – 7.85 (m, 6H), 7.85 – 7.79 (m, 6H), 7.71 
(dd, J = 8.4, 1.6 Hz, 3H), 7.70 – 7.65 (m, 9H), 7.65 – 7.55 (m, 15H), 7.51 (t, J = 7.7 Hz, 9H), 
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7.45 (d, J = 8.5 Hz, 3H), 4.39 (t, J = 7.2 Hz, 6H), 1.96 (p, J = 7.3 Hz, 6H), 1.51 – 1.23 (m, 18H), 
0.90 (t, J = 7.0 Hz, 9H). 
Physical data of 53c 1H NMR (400 MHz, CDCl3) δ 8.55 (d, J = 1.7 Hz, 3H), 8.47 (d, J = 1.4 Hz, 
3H), 8.06 (s, 3H), 7.97 (dd, J = 8.5, 1.8 Hz, 3H), 7.89 – 7.83 (m, 6H), 7.84 – 7.78 (m, 6H), 7.73 
– 7.58 (m, 24H), 7.56 (d, J = 8.6 Hz, 3H), 7.53 – 7.47 (m, 6H), 7.43 (d, J = 8.6 Hz, 3H), 4.37 (t, 
J = 7.2 Hz, 6H), 1.94 (p, J = 7.4 Hz, 7H), 1.50 – 1.16 (m, 42H), 0.93 – 0.82 (m, 9H). 
Physical data of 53e 1H NMR (500 MHz, CDCl3) δ 8.57 (s, γH), 8.48 (s, γH), 8.08 (s, γH), 7.λγ 
(d, J = 7.4 Hz, 3H), 7.89 – 7.84 (m, 6H), 7.84 – 7.79 (m, 6H), 7.70 – 7.63 (m, 15H), 7.63 – 7.56 
(m, 12H), 7.50 (t, J = 7.6 Hz, 9H), 4.60 – 4.37 (m, 3H), 1.35 – 1.25 (m, 12H), 0.83 (t, J = 7.3 Hz, 
18H). 
 
Physical data of 54D-c: 1H NMR (500 MHz, CDCl3) δ 8.64 – 8.56 (m, 16H), 8.40 (d, J = 1.5 Hz, 
8H), 8.29 (s, 4H), 8.11 (s, 8H), 8.08 (d, J = 8.7 Hz, 8H), 7.98 (d, J = 7.1 Hz, 4H), 7.74 (d, J = 
8.4 Hz, 4H), 7.65 (d, J = 9.1 Hz, 8H), 7.57 (d, J = 8.4 Hz, 4H), 7.49 (d, J = 8.7 Hz, 8H), 7.45 (d, 
J = 8.7 Hz, 4H), 7.29 (d, J = 7.2 Hz, 8H), 4.58 – 4.33 (m, 8H), 4.23 – 3.94 (m, 16H), 2.02 – 1.92 
(m, 8H), 1.84 – 1.72 (m, 16H), 1.58 – 1.20 (m, 168H), 0.79 (t, J = 7.0 Hz, 36H). MALDI-
TOF(m/z): [M +H]+ calcd. for C300H336N12, 4108.68; found: 4111.08. 
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Physical data of 54D-d: 1H NMR (500 MHz, CDCl3) δ 8.64 (s, 4H), 8.60 (s, 1βH), 8.γ8 (d, J = 
1.6 Hz, 8H), 8.30 (s, 4H), 8.13 (s, 8H), 8.10 (d, J = 8.1 Hz, 8H), 8.00 (d, J = 8.2 Hz, 4H), 7.60 – 
7.53 (m, 12H), 7.51 – 7.42 (m, 12H), 7.19 (d, J = 8.5 Hz, 8H), 4.28 (d, J = 7.4 Hz, 8H), 3.91 (d, 
J = 7.4 Hz, 16H), 2.15 – 2.07 (m, 4H), 1.96 – 1.88 (m, 8H), 1.51 – 1.28 (m, 48H), 1.02 (t, J = 
7.4 Hz, 72H). MALDI-TOF(m/z): [M]+ calcd. for C252H240N12, 3435.92; found, 3436.04. 
Due to purification difficulty, 54D-e was not successfully purified. 
The synthetic route for 54D-d from the free carbazole: 
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The reported synthetic procedure was followed. 31 1H NMR (500 MHz, CDCl3) δ 
7.80 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.0 Hz, 2H), 3.94 (d, J = 5.5 Hz, 2H), 2.46 (s, 
3H), 1.48 (q, J = 6.0 Hz, 1H), 1.40 – 1.26 (m, 4H), 0.80 (t, J = 7.5 Hz, 6H). 
49d: The reported synthetic procedure was followed. 32 1H NMR (500 MHz, CDCl3) δ 8.β4 (d, J 
= 7.8 Hz, 2H), 7.59 (td, J = 7.6, 6.7, 1.5 Hz, 2H), 7.52 (d, J = 8.3 Hz, 2H), 7.37 (t, J = 7.4 Hz, 
2H), 4.25 (d, J = 7.5 Hz, 2H), 2.14 (hept, J = 6.6 Hz, 1H), 1.70 – 1.40 (m, 4H), 1.06 (t, J = 7.4 
Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 141.1λ, 1β5.84, 1βγ.06, 1β0.58, 11λ.0γ, 118.λ7, 10λ.β5, 
47.31, 41.12, 24.15, 11.24. 
Physical data of 50d :1H NMR (500 MHz, CDCl3) δ 8.γγ (d, J = 1.7 Hz, 2H), 7.71 (dd, J = 8.6, 
1.7 Hz, 2H), 7.16 (d, J = 8.6 Hz, 2H), 4.09 (d, J = 7.5 Hz, 2H), 1.93 (hept, J = 6.7 Hz, 1H), 1.49 
– 1.23 (m, 4H), 0.92 (t, J = 7.5 Hz, 6H).  13C NMR (101 MHz, CDCl3) δ 140.1γ, 1γ4.68, 1βλ.5β, 
124.14, 111.40, 81.88, 47.41, 40.93, 24.00, 11.10. 
Physical data of 51d: 1H NMR (500 MHz, CDCl3) δ 8.γ7 (d, J = 1.7 Hz, 1H), 8.22 (d, J = 1.6 Hz, 
1H), 7.95 – 7.89 (m, 2H), 7.89 – 7.84 (m, 2H), 7.77 – 7.59 (m, 9H), 7.52 (dd, J = 8.3, 7.0 Hz, 
2H), 7.33 (d, J = 8.5 Hz, 1H), 7.14 (d, J = 8.6 Hz, 1H), 4.07 (d, J = 7.5 Hz, 2H), 1.94 (d, J = 7.5 
Hz, 1H), 1.45 – 1.26 (m, 4H), 0.93 (t, J = 7.5 Hz, 6H). 
Physical data of 52d: 1H NMR (500 MHz, CDCl3) δ 8.64 (s, 1H), 8.γ8 (d, J = 1.5 Hz, 1H), 7.95 
(dd, J = 8.3, 1.1 Hz, 1H), 7.94 – 7.91 (m, 2H), 7.88 – 7.84 (m, 2H), 7.76 (d, J = 8.3 Hz, 2H), 
7.71 – 7.60 (m, 6H), 7.53 (t, J = 7.7 Hz, 2H), 7.43 – 7.36 (m, 2H), 4.20 (d, J = 7.5 Hz, 2H), 2.01 
(p, J = 6.8 Hz, 1H), 1.40 – 1.31 (m, 4H), 0.94 (t, J = 7.4 Hz, 6H). 13C NMR (101 MHz, CDCl3) 
δ 1λ6.47, 144.64, 14γ.6γ, 140.λ1, 1γλ.1λ, 1γ7.λ6, 136.58, 132.77, 132.67, 132.28, 131.05, 
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130.26, 129.50, 128.59, 128.23, 127.40, 127.01, 124.53, 124.22, 123.39, 122.40, 113.78, 109.43, 
108.94, 92.56, 87.70, 83.90, 47.38, 40.96, 25.22, 25.14, 24.03, 11.14. 
Physical data of 53d: 1H NMR (500 MHz, CDCl3) δ 8.57 (d, J = 1.8 Hz, 3H), 8.48 (d, J = 1.1 Hz, 
2H), 8.07 (s, 3H), 7.98 (dd, J = 8.5, 1.8 Hz, 3H), 7.90 – 7.85 (m, 6H), 7.85 – 7.80 (m, 6H), 7.73 
– 7.66 (m, 18H), 7.65 – 7.59 (m, 6H), 7.57 (d, J = 8.5 Hz, 3H), 7.54 – 7.48 (m, 6H), 7.44 (d, J = 
8.6 Hz, 3H), 4.27 (d, J = 7.4 Hz, 6H), 2.09 (hept, J = 6.7 Hz, 3H), 1.55 – 1.39 (m, 12H), 1.00 (t, 
J = 7.4 Hz, 18H). 
 
50h was synthesized following the similar procedure of synthesis of 50i. 1H NMR (500 MHz, 
CDCl3) δ 8.β4 (d, J = 1.8 Hz, 2H), 8.05 (d, J = 8.8 Hz, 2H), 7.77 (dd, J = 8.8, 1.8 Hz, 2H), 4.53 
(t, J = 6.7 Hz, 2H), 1.91 (p, J = 6.9 Hz, 2H), 1.45 – 1.20 (m, 27H), 0.89 (t, J = 6.9 Hz, 3H). 
Physical data of 51h: 1H NMR (500 MHz, CDCl3) δ 8.γ4 (d, J = 1.8 Hz, 1H), 8.30 (d, J = 8.7 Hz, 
1H), 8.16 (d, J = 1.8 Hz, 1H), 8.10 (d, J = 8.7 Hz, 1H), 7.93 (d, J = 8.3 Hz, 2H), 7.89 – 7.84 (m, 
2H), 7.79 (dd, J = 8.8, 1.8 Hz, 1H), 7.76 (d, J = 8.4 Hz, 2H), 7.69 (s, 5H), 7.53 (t, J = 7.6 Hz, 
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2H), 4.57 (t, J = 6.7 Hz, 2H), 1.93 (tt, J = 13.5, 7.2 Hz, 2H), 1.55 – 1.23 (m, 26H), 0.95 – 0.87 
(m, 3H). 
Physical data of 53h: 1H NMR (500 MHz, CDCl3) δ 8.4λ – 8.42 (m, 3H), 8.40 (d, J = 1.8 Hz, 
3H), 8.38 – 8.32 (m, 6H), 8.06 (s, 3H), 7.96 (dd, J = 8.7, 1.9 Hz, 3H), 7.90 – 7.85 (m, 6H), 7.82 
(dd, J = 8.2, 1.4 Hz, 6H), 7.72 (dd, J = 8.6, 1.7 Hz, 3H), 7.71 – 7.64 (m, 12H), 7.64 – 7.58 (m, 
9H), 7.51 (t, J = 7.7 Hz, 6H), 4.61 (t, J = 6.8 Hz, 6H), 1.98 (q, J = 7.1 Hz, 6H), 1.48 – 1.41 (m, 
6H), 1.40 – 1.17 (m, 72H), 0.89 (t, J = 7.0 Hz, 9H). MALDI-TOF MS: calcd. for [M+H]+ 
C105H60N3O3: 1412.48, found: 1413.39. 
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CHAPTER 4 
 
 
A Dimeric Triangular Prism and Its Interlocked Cages Synthesized via Alkyne Metathesis 
 
 
 
4.1. Introduction 
Interlocked molecules, by definition, are molecules that are mechanically linked and have 
to break at least one covalent bond to divide into two or more molecular components.1-2 These 
molecules, such as rotaxanes, knots, catenanes, are mechanically interlocked to each other that 
only have noncovalent interactions. Apparently, these molecules with interesting topologies 
endowed great synthetic difficulty. The first 2-D catenane designed and synthesized using ion-
templated method was reported by Sauvage in 19833. This work inspired a tremendous amount 
of topologically interesting molecules being designed and synthesized via metal-ion, e.g. 
catenanes, rotaxanes, knots and links, and increased the synthetic yields dramatically.4-5 
However, 3-D interlocked cages were discovered much later in 1999 by the Fujita group. The 
triply interlocked metal organic dimeric cages quickly formed and existed as the main product in 
the system. More interestingly, there was no strong directing effect or template effect in the 
system.6 Later, more metal organic interlocked cages were reported with different topologies by 
Kuroda7, Hardie8 and Clever9-10. The metal-organic polycatenanes 56 were also discovered by 
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Lu11. With the development of covalent organic polyhedrons, interlocked covalent 3-D cages 
were also discovered but more rarely. The first three covalent interlocked 3-D cages were 
reported by the Cooper group in 201012. They observed the tetrahedral monomeric cages can 
slowly transform into triply interlocked dimeric cages in solution and crystalize out to drive the 
transformation equilibrium. Very recently in 2014, Mastalerz and coworkers crystalized out 
another interlocked giant COPs from its mono-cage compound solution13. To our best knowledge, 
these two works are the only reported interlocked covalent cages by now. In this work, a 
carbazole based covalent organic triangular prism and its interlocked cages synthesized through 
one-step alkyne metathesis will be discussed.  
 
Figure 4.1. a) The crystal structure of interlocked MOP cage 56 reported by the Fujita group; b) 
the two interlocked cages in the polycatenane 56 reported by the Lu group; c) the synthetic 
scheme and crystal structure of one interlocked COP cage 57 reported by the Cooper group. 
55
a) b)
56
57
c)
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4.2. Results and Discussion 
Given the dynamic nature of alkyne metathesis (a newly emerged DCvC reaction for COP 
synthesis), its final product is usually the most thermodynamically favored. This is the key factor 
that leads to the formation of the dumbbell-shaped cage 54D through alkyne metathesis as 
described in Chapter 3. The computational modeling result supports that the energy of two 
dimeric cages 54A is indeed much higher than one dumbbell-shaped cage 54D. We believe that 
the 87.4o angle of 3,6-disubstituted carbazole, which is less than the ideal 90o angle, induces 
angle strain thus elevating the energy of the dimeric cage. However, interestingly, with the same 
carbazole motif to provide a roughly the 90o vertex on a flat top piece, the reported porphyrin-
based dimeric cage 35 showed high yield through alkyne metathesis.14 This observation leads us 
to the further investigation of the rules in construction of the shape-persistent covalent organic 
polyhedrons. 
The main differences between the dumbbell-shaped cage and the porphyrin-based cage 
are 1) the center of dumbbell-shaped cage 54D is a phenyl group and the center of 35 is a 
porphyrin; 2) 54D contains 3 arms, and 35 contains 4 arms. The number of arms could affect the 
shape-persistency of one compound (e.g., 4-arm porphyrin cage 3514 vs. 2-arm porphyrin 
macrocycle 3615), but cage compounds with 3 arms vs. 4 arms should have similar shape-
persistency and conformational stability. Given such consideration, we doubt that only the 
difference in the number of arms could induce the formation of cage structures with totally 
different topology. Therefore the size of the center piece of the monomer drew our attention. We 
speculate that the larger center piece would have relatively larger out-of-plane bending vibration 
that can release the angle strain introduced by the carbazole building block to certain extent, thus 
decreasing the enthalpy of the cage compound.  
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In order to study the dependence of cage formation on different building blocks, we 
designed the extended monomer 58a with one more phenyl group installed on each arm (Scheme 
4.1). Using catalyst 1 in CCl4 and CHCl3 mixed solvent at 35 oC, alkyne metathesis of monomer 
58a was conducted, after which, one major peak was observed on GPC. MALDI-TOF MS 
showed mainly a tetrameric species formed, along with dimer and even hexamer and octamer 
signals. TLC mainly showed two spots. Because of the difficulty in separating these two 
fractions using flash chromatography, prep TLC was used and two pure fractions were 
successfully obtained. The first fraction was confirmed by NMR and MALDI-TOF MS to be 
dimeric cage 59A-a. In contrast to the NMR spectrum of the dumbbell-shaped cage 54D, the 1H 
NMR (Figure 4.2) of this dimeric cage only shows one set of signals corresponding the cage 
backbones and side chains instead of two sets with 2:1 ratio (Figure 3.1), which indicates that all 
three arms are identical. Compared with previously described dumbbell shape cage 54D, we 
believe that the larger bending vibration of the extended center piece helped with the release of 
side arm strain caused by not fully matched geometry angle. Thus during the dimer formation, 
enthalpy was not sacrificed to a significant degree. In this case, the dimeric cage formed 
favorably. This observation supported the previous assumption that a larger center piece would 
provide more out-of-plane bending vibrations, thus lowering the enthalpy of dimeric product, 
which will result in dimer cages with higher entropy contribution.     
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Scheme 4.1. The synthetic scheme of cage 59A-a and 59B-a. 
 
Figure 4.2. The structure of dimeric cage 59A-a and its 1H NMR spectrum in CDCl3.  
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However, the main product of this reaction was the second isolated fraction which was 
proved to be a tetramer by MALDI-TOF MS. The possible configurations of a tetrameric cage 
include 1) tetrahedral cage; 2) dumbbell-shaped cage; 3) interlocked cages. Thus, further NMR 
characterization was conducted. Surprisingly, the room temperature 1H NMR signal is very 
broad (Figure 4.3) compared to both the dumbbell shape cage 54D and the dimeric cage 59A-a. 
Variable-temperature NMR and low temperature ROESY experiments were taken in order to 
investigate if the broad signals come from conformational change or configurational complexity. 
It is well known that if it is induced by configuration complexity (bond connection complexity), 
there should be no significant change on NMR signals at various temperatures. But if it is due to 
conformation exchange, the shape of the NMR peaks should change upon varying temperatures 
since the rate of conformation exchange depends on temperature. The variable-temperature NMR 
spectra (Figure 4.3) showed a dramatic change of both chemical shift and the shape of peaks at 
high or low temperatures. At -50 oC, the broad peaks observed at room temperature NMR 
spectrum were much sharper and well resolved, which means lower temperature slows down the 
conformation exchange. After increasing the temperature to 58 oC, a large number of peaks 
coalesced, giving fewer peak numbers, which is due to faster exchange rate at elevated 
temperature. This represents a strong evidence indicating that the conformation exchange 
contributed to peak broadening and complexity. ROESY experiment (Figure 4.11) also 
supported that chemical/conformational exchange existed in the 59B-a sample at -50 oC. Since 
the cages were covalently bonded, there was no chemical exchange. These ROESY cross peaks 
were from conformational exchange. Given these characterization data, we believe that the 
tetrameric species 59B-a 1) does not take the similar configuration as the dumbbell-shaped cage 
or tetrahedral cage, since the symmetry of the NMR signal was much lower than the dumbbell-
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shaped or tetrahedral one; 2) should have low energy barrier on conformation exchange which 
can be observed at NMR time scale.  
 
Figure 4.3. The variable-temperature NMR spectra of product 59B-a at 58 oC (top), 20 oC 
(middle) and -50 oC (bottom). 
However, given the difficulty in separation 59a-A from 59B-a, only limited amount of 
pure materials can be obtained from prep TLC separation. In order to synthesize 59A and 59B 
more efficiently and study the structure of 59B, later, a carbazole based cage substituted with 
ester groups was synthesized (scheme 4.2). The resulting dimeric and tetrameric cages exhibit 
very different polarity, which makes the purification much easier. However, although the cage 
products can be easily purified, the yield of the Suzuki coupling reaction to synthesize monomer 
58f is very low. Therefore another carbazole based cage substituted with Boc group was 
designed. The synthetic route worked out in good overall yield as shown in scheme 4.3. 9-Boc-
3,6-diiodocarbazole was obtained following a reported procedure16, followed by the Sonagashira 
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coupling with the compound 48 to give the carbazole arm 51j. The center piece 60 was 
synthesized from the coupling of 1,3,5-tris(p-bromophenyl)benzene with bis(pinacolato)diboron, 
followed by Suzuki coupling with arm 51j, affording the final monomer 58j.   
 
Scheme 4.2. The synthetic scheme of monomer 58f. 
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Scheme 4.3. The synthetic scheme of cage 59A-j and 59B-j. 
After alkyne metathesis, one major peak showed up on GPC (Figure 4.4) with a 
polydispersity index (PDI) of 1.13. Similar as what we observed for 59-a cage formation, 
MALDI-TOF MS analysis of crude reaction mixture showed mainly tetramers with a small 
amount of dimers, and even a trace of hexamers and octamers were detected. The 1H NMR of the 
crude mixture was very complicated, drifted baseline with sharp peaks on top of it was observed 
(Figure 4.5). After purification through column chromatography, two fractions were collected. 
The first fraction was identified as dimeric cage 59A-j after full characterization using 1H, 13C 
NMR, GPC and MALDI-TOF MS. As expected, the 1H NMR is very similar as 59A-j.    
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Figure 4.4. Normalized GPC data of the crude reaction mixture of cage formation (blue), 
isolated dimeric cage 59A-j (red, PDI=1.04, Mn =2445, Mw =2539) and isolated interlocked cage 
59B-j (black, PDI=1.05, Mn=3000, Mw=3164).  
 
 
Figure 4.5. The 1H NMR of crude reaction mixture of cage 59-j formation in CDCl3. 
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Figure 4.6. The structure of dimeric cage 59A-j and its 1H NMR spectrum in CDCl3.  
The main product of this reaction was the second isolated fraction which was proved to 
be a tetramer by GPC and MALDI-TOF MS. Surprisingly, the room temperature 1H NMR signal 
(Figure 4.7) was not as broad as that of 59B-a (Figure 4.3, middle), and it is more comparable 
with the NMR spectrum of 59B-a at -50 oC. This observation suggests that the Boc protected 
interlocked-cage compound 59B-j may have higher energy barrier to the relative movement of 
two cage units in one interlocked-cage complex and slow down the conformational exchange, 
indicating that the side arms could affect the relative motion rate of two cage units in one 
interlocked-cage complex. One possible reason is that the Boc group containing a bulky tert-
butyl group provided more steric hinderance compared to a linear alkyl chain. Variable-
temperature NMR experiments were also conducted (Figure 4.10). Elevated temperature 
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accelerated the conformation exchange, so the higher temperature NMR showed some coalesced 
peaks with similar trend as the cage 59B-a. However, different from 59B-a, some peaks were 
getting broader in lower temperature NMR. One possible reason is that the solubility of cage 
59B-j with Boc groups is poor, thus at low temperature, the aggregation occurs, resulting in 
signal broadening.  
 
Figure 4.7. Aromatic region of 1H NMR spectrum of product 59B-j at 20 oC.  
Based on NMR and MALDI-TOF MS characterization, the product 59B are likely the 
interlocked cages. Although the possibility of this product is narrowed down to interlocked cages, 
there is still more than one possible structure. As shown in figure 4.8, two cages have two 
possible ways to interlock, side-by-side or face-to-face. The interlocked cages reported by Fujita, 
Cooper and Kuroda claimed that the - stacking interactions stabilized the face-to-face dimer 
cages based on their XRD data. However, another face-to-face interlocked-cage complex 
reported by Hardie and coworkers showed weak hydrogen bonding instead of - stacking. 
Interestingly, among all reported cases, only the polycatenanes reported by the Lu group 
intercatenated in a side-by-side fashion11. All the other interlocked cages were face-to-face 
interconnected based on the XRD data. In our case, unfortunately, the single crystal of the 
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the size difference of dimeric cage 59A-j and interlocked cages 59B-j. Although based on these 
results, it is still inconclusive that whether the 59B-j is pure face-to-face or side-by-side 
interlocked cages or a mixture of both, it further supported that fraction 59B-j is an interlocked 
species.     
A kinetic study of the cage formation of 59A-j and 59B-j was conducted in order to 
understand the alkyne metathesis process. Aliquots of the reaction mixture were withdrawn after 
0.5 h, 1 h, 4 h, 8 h and 23 h and 48 h (new batch of catalyst was added after 24 h), and analyzed 
by GPC, MALDI-TOF MS and 1H NMR spectroscopy. Interestingly, the GPC data indicated that 
there was no much change from 0.5 h to 23 h, and the 48 h data showed the peak shifted to 
higher molecular weight direction with decreased shoulder peak (Figure 4.12). MALDI-TOF MS 
clearly indicated that both dimeric cage and tetrameric cages formed at 0.5 h of the reaction. 
Qualitatively, the intensity of dimer cage peak is stronger than the tetrameric cage peak from 0.5 
h to 23 h. While the 48 h MALDI-TOF MS shows reversed result. The m/z intensity of 
tetrameric cage is much stronger, which is consistent with the GPC data at 48 h. However, NMR 
data showed continuous change in the first 4 h of the reaction. During this period, the baselines 
turned flatter and the dimeric cage peaks were sharper. It indicated that the cage species were 
forming mainly in the first 4 h. No obvious change on NMR after 4 h with clear dimeric cage 
59A-j peaks showed up, indicating the cage formation completed after 4 h. This observation 
indicates that both the dimeric cage and tetrameric cage formations are very fast. But the 
transformation from dimeric cage to tetrameric interlocked cages is relatively slow based on the 
GPC and MALDI-TOF MS results. (The NMR signal of interlocked cages was broad, so it is 
difficult to identify the ratio of dimeric cage vs. interlocked cages.) 
  - 120 - 
 
4.3. Conclusion 
We designed and synthesized dimeric cages 59A-a and 59A-j and their interlocked cages 
59B-a and 59B-j with different side chains through alkyne metathesis. The extended center piece 
of monomer 58 promoted the dimer cage 59A formation instead of the dumbbell-shaped cage 
which proved that more out-of-plane bending vibration of a flat center piece could release the 
angle strain of a cage product to certain extent, thus lowering the enthalpy of dimer products. 
The interlocked cages 59B-a and 59B-j exhibited different rate of conformation exchange which 
suggests that the side chains could affect the relative motion of two cage units in one interlocked 
cages. However, whether the interlocked cages 59B take the face-to-face or side-by-side 
intercatenated motif is still open to speculation.  
4.4. Experimental Section 
4.4.1. Materials and general synthetic methods 
Reagents and solvents were purchased from commercial suppliers and used without 
further purification, unless otherwise indicated. Tetrahydrofuran (THF), toluene, CH2Cl2 and 
dimethylformamide (DMF) were purified by the MBRAUN solvent purification systems.  
All reactions were conducted under dry nitrogen in oven-dried glassware, unless 
otherwise specified. All the alkyne metathesis reactions were conducted in glovebox. The 
solvents used in alkyne metathesis were dried over 4 Å molecular sieves. Solvents were 
evaporated using a rotary evaporator after workup. Unless otherwise specified, the purity of the 
compounds was 1 95 % based on 1H NMR spectral integration. 
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Flash column chromatography was performed by using a 100-150 times weight excess of 
flash silica gel 32-6γ ȝm from Dynamic Absorbants Inc. Fractions were analyzed by TLC using 
TLC silica gel Fβ54 β50 ȝm precoated-plates from Dynamic Absorbants Inc. Analytical gel 
permeation chromatography (GPC) was performed using a Viscotek GPCmaxTM, a Viscotek 
Model 3580 Differential Refractive Index (RI) Detector, a Viscotek Model 3210 UV/VIS 
Detector and a set of two Viscotek Viscogel columns (7.8 × 30 cm, l-MBLMW-3078, and l-
MBMMW-3078 columns) with THF as the eluent at 30 °C. The analytical GPC was calibrated 
using monodisperse polystyrene standards. UV-vis absorption measurements were carried out 
with Agilent 8453 spectrophotometer. 
MALDI-TOF Mass spectra were obtained on the Voyager-DE™ STR Biospectrometry 
Workstation using sinapic acid (SA) as the matrix. The high resolution mass spectra were 
obtained on Waters SYNAPT G2 High Definition Mass Spectrometry System. Analyte 
molecules were diluted into ESI solvents, methanol, chloroform or acetonitrile/water mixture, for 
final concentrations of 10 ppm or lower.  The solution was injected into the electrospray 
ionization (ESI) source at a rate of 5 L/min. Either the ESI+ or ESI− mode was used in 
reference to the molecular properties. Accurate mass analysis was performed by using the Lock 
Mass calibration feature with the instrument.   
NMR spectra were taken on Inova 400 and Inova 500 spectrometers. CHCl3 (7.27 ppm), 
toluene-d8 (2.09 ppm) were used as internal references in 1H NMR, and CHCl3 (77.00 ppm) for 
13C NMR.  1H NMR data were reported in order: chemical shift, multiplicity (s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet), coupling constants (J, Hz), number of protons. 
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4.4.2. Compounds Preparation 
 
1,3,5-Tri(4-bromophenyl)benzene was synthesized following the 
reported procedure. 17 1H NMR (500 MHz, CDCl3) δ 7.70 (s, γH), 7.6β (d, 
J = 8.5 Hz, 5H), 7.55 (d, J = 8.5 Hz, 6H). 
58a was synthesized following general Suzuki 
coupling reaction procedure. 52a (965 mg, 1.21 
mmol), 1,3,5-tri(4-bromophenyl)benzene (146 mg, 
0.269 mmol), Pd(PPh3)4 (32 mg, 0.027 mmol) and 
Na2CO3 (0.3 M, 10 mL aqueous solution) were 
used. Product (480 mg, 77%) was purified by 
column chromatography (hexanes/CH2Cl2, 1/1~0/1, 
v/v). 1H NMR (500 MHz, CDCl3) δ 8.4β (d, J = 1.5 
Hz, 6H), 7.98 (s, 3H), 7.95 – 7.82 (m, 27H), 7.79 – 7.65 (m, 21H), 7.64 – 7.59 (m, 3H), 7.51 (tt, 
J = 7.4, 5.3 Hz, 9H), 7.42 (d, J = 8.5 Hz, 3H), 4.34 (t, J = 7.2 Hz, 6H), 1.93 (p, J = 7.5 Hz, 6H), 
1.48 – 1.15 (m, 78H), 0.88 (t, J = 6.9 Hz, 9H). 
Synthesis of 59A-a and 59B-a:  
Following the typical alkyne metathesis reaction procedure. To a monomer 58a (391 mg, 0.167 
mmol) in CHCl3 (5mL) and CCl4 (13 mL) solution was added newly prepared catalyst 1 solution 
(precursor 10.1 mg, 0.0152 mmol and amine ligand 7.1 mg, 0.0152 mmol). The reaction was 
heated to 35 oC overnight. The reaction was monitored by GPC. After normal workup, the 
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product was purified by column chromatography (hexanes/CH2Cl2, 2.5/1, v/v). The unseparated 
mixture were further purified using prep TLC (eluting with hexanes/CH2Cl2, 2.5/1, v/v).  
Dimeric cage 59A-a: 1H NMR (500 MHz, CDCl3) δ 8.4γ 
(d, J = 1.6 Hz, 6H), 8.38 (d, J = 1.7 Hz, 6H), 7.90 (s, 6H), 
7.88 – 7.81 (m, 24H), 7.78 (dd, J = 8.6, 1.8 Hz, 6H), 7.71 
(dd, J = 8.4, 1.6 Hz, 6H), 7.51 (d, J = 8.6 Hz, 6H), 7.41 (d, J 
= 8.5 Hz, 6H), 4.35 (s, 12H), 2.00 – 1.87 (m, 12H), 1.51 – 
1.14 (m, 156H), 0.87 (t, J = 6.9 Hz, 16H). MALDI-
TOF(m/z): [M]+ calcd. for C222H263N6, 3016.09; found, 
3015.08.  
Interlocked cages 59B-a: MALDI-TOF(m/z): [M]+ calcd. for C444H526N12, 6032.18; found, 
6033.60.  
Ethyl 5-(9H-carbazol-9-yl)pentanoate (49f): 5-Bromopentanoic acid 
(5.00 g, β7.6 mmol), EtOH (β5 mL) and concentrated HβSO4 (0.1β mL) 
were added to a seal tube. The reaction was reflux for β h and solvent was removed under 
vacuum to get the crude product (5.01 g). The crude product was used directly in the next step. 
To a seal tube, ethyl 5-bromopentanoate (5.01 g, β4 mmol), carbazole (β.00 g, 1β mmol) and 
KβCOγ (4.80 g, γ4.5mmol) and dry DMF (γ0 mL) were added, and the mixture was heated to 80 
oC for β days. Then the reaction was quenched by cold water (50 mL). Then the product was 
extracted by hexanes (100 mL × γ) and dried over NaβSO4. After removing the solvent, the crude 
product was purified by flash column chromatography (hexanes/EtOAc/CHClγ, 7/1/7, v/v/v). 
γ.184 g pure product was collected (78% yield in two steps). 1H NMR (400 MHz, CHClγ) δ 8.0λ 
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(d, J = 7.7 Hz, βH), 7.4λ – 7.4β (m, βH), 7.γλ (d, J = 8.β Hz, βH), 7.ββ (t, J = 7.7 Hz, βH), 4.γβ 
(t, J = 7.1 Hz, βH), 4.08 (q, J = 7.1 Hz, βH), β.γ0 (t, J = 7.γ Hz, βH), 1.λ7 – 1.8γ (m, βH), 1.78 – 
1.66 (m, βH), 1.β0 (t, J = 7.1 Hz, γH). HRMS (m/z)μ [M+Li]+ calcd. for C1λHββNOβ, βλ6.1645; 
found, βλ6.1655. 
Ethyl 5-(3,6-diiodo-9H-carbazol-9-yl)pentanoate (50f): To a round 
bottom flask, ethyl 5-(λH-carbazol-λ-yl)pentanoate (49f) (β.18 g, 7.γλ 
mmol), NIS (γ.66g, 16.β mmol) were dissolved in CHClγ (50 mL) and 
HOAc (11 mL). The reaction mixture was stirred at room temperature for 4.5 h. After the 
reaction, the solvent was reduced under rotavap to 15 mL and filter to collect the precipitates. 
The precipitates were washed with cold hexanes. The white solids (γ.λ4 g, λ7%) were collected 
as pure product. 1H NMR (500 MHz, CHClγ) δ 8.γ4 (d, J = 1.7 Hz, βH), 7.7β (dd, J = 8.6, 1.7 
Hz, βH), 7.1λ (d, J = 8.6 Hz, βH), 4.β7 (t, J = 7.1 Hz, βH), 4.10 (q, J = 7.1 Hz, βH), β.γ0 (t, J = 
7.β Hz, βH), 1.λβ – 1.8γ (m, βH), 1.7γ – 1.6β (m, βH), 1.β1 (t, J = 7.1 Hz, γH). 1γC NMR (101 
MHz, CHClγ) δ 17γ.1γ, 140.βγ, 1β5.58, 1ββ.76, 1β0.γ1, 118.76, 108.51, 60.γ1, 4β.5λ, γγ.84, 
β8.γ6, ββ.61, 14.14. HRMS (m/z)μ [M]+ calcd. for C1λH1λLiIβNOβ, 55β.λ6γ4; found, 55β.λ656. 
HRMS (m/z)μ [M+Li]+ calcd. for C1λH1λLiIβNOβ, 55β.λ65λ; found, 55β.λ6γ4. 
51fμ Follow normal Sonagashia coupling reaction procedure. 
Ethyl 5-(γ,6-diiodo-λH-carbazol-λ-yl)pentanoate (50f) (γ.77 
g, 7.β0 mmol), PPT H (48) (β.γγ g, 8.6γ mmol), 
Pd(PPhγ)βClβ (150 mg, 0.βλ mmol) and CuI (5 mg, 0.0β6 
mmol), THF (15 mL) and piperidine (4 mL) were used. 
After purified by flash chromatography eluting with 
(hex/EA/CHClγ, 7/1/7~5/1/5, v/v/v), pure product (β.γ6γ g, 4λ %) was collected. 1H NMR (500 
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MHz, CHClγ) δ 8.41 (d, J = 1.6 Hz, 1H), 8.β6 (d, J = 1.5 Hz, 1H), 7.λγ (d, J = 8.γ Hz, βH), 7.88 
– 7.8γ (m, βH), 7.7λ – 7.71 (m, γH), 7.71 – 7.66 (m, 5H), 7.65 – 7.60 (m, 1H), 7.5γ (dd, J = 8.γ, 
7.0 Hz, βH), 7.γλ (d, J = 8.5 Hz, 1H), 7.β1 (d, J = 8.6 Hz, 1H), 4.γ1 (t, J = 7.1 Hz, βH), 4.11 (q, J 
= 7.β Hz, βH), β.γγ (t, J = 7.β Hz, βH), 1.λ8 – 1.84 (m, βH), 1.7λ – 1.64 (m, βH), 1.βγ (t, J = 7.β 
Hz, γH). 1γC NMR (101 MHz, CHClγ) δ 1λ6.16, 17β.λ4, 144.β4, 1γλ.8γ, 1γλ.7γ, 1γλ.0β, 1γ7.58, 
1γ6.βλ, 1γ4.γ1, 1γβ.γ6, 1γ1.λ5, 1γ0.7β, 1βλ.λβ, 1βλ.γβ, 1β8.β6, 1β7.10, 1β6.6λ, 1β4.80, 1β4.16, 
1βγ.64, 1β1.5γ, 11γ.71, 110.84, 108.84, λ1.78, 87.6β, 81.λ1, 60.γ8, 4β.85, 40.λβ, γγ.6λ, β8.β4, 
ββ.48, 14.15. HRMS (m/z)μ [M+Li]+ calcd. for C40HγβLiINOβ, 708.1588; found, 708.15λ1. 
52fμ To a seal tube, 51f (1.λ65 g, β.80 mmol), 
bis(pinacolato)diboron (1.067 g, 4.β mmol), 
Pd(dppf)Clβ (61 mg, 0.084 mmol) and KOAc (8β4 mg, 
8.4 mmol) were added. After vacuum and refill with 
Nβ three times, DMSO (β0 mL) was added under Nβ 
flow. Then the reaction was heated to λ0 oC. After 
stirring for 18 h, the reaction mixture was cooled to room temperature and ethyl acetate (50 mL) 
was added to the mixture and the mixture was washed with water (100 mL × γ). The organic 
layer was collected and washed with brine (50 mL). After drying over NaβSO4, solvent was 
removed under reduced pressure and the residue was purified by flash chromatography (eluting 
with hexanes/EtOAc/CHClγ, 5/1/γ) yielding yellow product (805 mg, 41%). 1H NMR (500 MHz, 
CHClγ) δ 8.6γ (s, 1H), 8.γ7 (d, J = 1.5 Hz, 1H), 7.λ5 (dd, J = 8.β, 1.1 Hz, 1H), 7.λ4 – 7.λ1 (m, 
βH), 7.86 (dd, J = 8.γ, 1.4 Hz, βH), 7.76 (d, J = 8.γ Hz, βH), 7.68 (s, 4H), 7.67 (dd, J = 8.5, 1.7 
Hz, 1H), 7.65 – 7.60 (m, 1H), 7.5γ (dd, J = 8.γ, 7.1 Hz, βH), 7.41 (d, J = 8.γ Hz, 1H), 7.γλ (d, J 
= 8.5 Hz, 1H), 4.γ5 (t, J = 7.1 Hz, βH), 4.11 (q, J = 7.1 Hz, βH), β.γβ (t, J = 7.β Hz, βH), 1.λ8 – 
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1.8λ (m, βH), 1.76 – 1.68 (m, βH), 1.ββ (t, J = 7.1 Hz, γH). HRMS (m/z)μ [M+Li]+ calcd. for 
C46H4βLiBINOβ, 708.γ481; found, 708.γ51λ. 
Monomer 58fμ To a Schlenk tube 52f (270 mg, 0.385 
mmol), 1,3,5-tri(4-bromophenyl)benzene (52.2 mg, 0,096 
mmol), Pd(PPh3)4 (16.7 mg, 0.0144 mmol) were charged. 
Toluene
 
(2 mL), Na2CO3 solution (1M, 0.8 mL) and EtOH 
(0.8 mL) were added under N2 flow. The reaction was 
stirred at 110 oC for 16 h. The aqueous phase was discarded 
after separation. The organic phase was washed with NH4Cl (sat. 50 mL) and brine (50 mL). The 
organic extracts were dried over Na2SO4, and concentrated. The residue was purified by flash 
column chromatography (hexanes/CHCl3/EtOAc, 4/4/1~2/3/1) to give the product as a yellow 
solid (27.6 mg, 14 %). 1H NMR (400 MHz, CDCl3) δ 8.γ8 (d, J = 1.0 Hz, 6H), 7.95 (s, 3H), 7.92 
– 7.76 (m, 27H), 7.74 – 7.55 (m, 24H), 7.53 – 7.43 (m, 9H), 7.37 (d, J = 8.5 Hz, 3H), 4.32 (t, J = 
7.0 Hz, 6H), 4.10 (q, J = 7.1 Hz, 6H), 2.33 (t, J = 7.2 Hz, 6H), 2.03 – 1.85 (m, 6H), 1.80 – 1.62 
(m, 6H), 1.22 (t, J = 7.2 Hz, 9H). 13C NMR (101 MHz, CDCl3) δ 1λ6.βγ, 17γ.10, 1γβ.γλ, 1γ1.λλ, 
130.78, 129.98, 128.30, 127.81, 127.65, 127.16, 126.74, 
124.25, 123.85, 123.06, 118.95, 113.37, 109.23, 92.21, 
87.53, 60.44, 33.83, 29.71, 28.45, 22.63, 14.22. 
Physical data of 59A-f:  1H NMR (500 MHz, CDCl3) δ 8.4γ 
(d, J = 1.6 Hz, 6H), 8.37 (d, J = 1.7 Hz, 6H), 7.90 (s, 6H), 
7.89 – 7.81 (m, 24H), 7.78 (dd, J = 8.5, 1.8 Hz, 6H), 7.72 
(dd, J = 8.5, 1.7 Hz, 6H), 7.51 (d, J = 8.6 Hz, 6H), 7.42 (d, J 
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= 8.5 Hz, 6H), 4.47 – 4.31 (m, 5H), 4.12 (q, J = 7.2 Hz, 12H), 2.41 – 2.33 (m, 12H), 2.06 – 1.94 
(m, 12H), 1.86 – 1.72 (m, 12H), 1.23 (t, J = 7.1 Hz, 18H).  MALDI-TOF MS: calcd. for [M]+ 
C168H144N6O12: 2438.09, found: 2438.34. 
Physical data of 59B-f: MALDI-TOF MS: calcd. for [M]+ C336H288N12O24: 4876.18, found: 
4871.97 . 
60: To a Schlenk tube 1,3,5-tris(p-bromophenyl)benzene (680 
mg, 1.252 mmol), bis(pinacolato)diboron (1.00 g, 3.94 mmol), 
Pd(dppf)Cl2 (91.5 mg, 0.125 mmol) and KOAc (1.47 g, 15.0 
mmol) were charged. DMF
 
(15 mL) was added under N2 flow. 
The reaction was stirred at 80 oC for 16 h. The solvent was 
removed by vacuum evaporation, the crude reaction mixture 
was dissolved in CH2Cl2 (40 mL) and washed with NH4Cl (sat., 60 mL) and brine (70 mL). The 
organic extracts were dried over Na2SO4, and concentrated. The residue was purified by flash 
column chromatography (1% MeOH in CH2Cl2) to give the product as a white solid (778 mg, 
91 %).1H NMR (400 MHz, CDCl3) δ 7.λ4 (d, J = 7.9 Hz, 6H), 7.83 (s, 3H), 7.72 (d, J = 7.9 Hz, 
6H), 1.39 (s, 36H). 13C NMR (101 MHz, CDCl3) δ 
143.67, 142.22, 135.32, 126.66, 125.54, 109.99, 
83.84, 24.87. 
Monomer 58j: To a Schlenk tube 60 (255 mg, 
0.373 mmol), 51j (1.25 g, 1.86 mmol), Pd(PPh3)4 
(55 mg, 0.048 mmol) were charged. Toluene
 
(65 
mL), Na2CO3 solution (1M, 8 mL) and EtOH (8 mL) 
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were added under N2 flow. The reaction was stirred at 90 oC for 12 h. The aqueous phase was 
discarded after separation. The organic phase was washed with NH4Cl (sat. 100 mL) and brine 
(100 mL). The organic extracts were dried over Na2SO4, and concentrated. The residue was 
purified by flash column chromatography (hexanes/CHCl3/EtOAc, 30:10:1) to give the product 
as a yellow solid (469 mg, 65 %). 1H NMR (500 MHz, CDCl3) δ 8.41 (d, J = 8.7 Hz, 3H), 8.36 (d, 
J = 8.7 Hz, 3H), 8.34 – 8.30 (m, 6H), 7.99 (s, 3H), 7.96 – 7.88 (m, 18H), 7.88 – 7.83 (m, 9H), 
7.75 (d, J = 8.3 Hz, 6H), 7.74 – 7.67 (m, 15H), 7.65 – 7.59 (m, 3H), 7.52 (t, J = 7.7 Hz, 6H), 1.83 
(s, 27H). 13C NMR (101 MHz, CDCl3) δ 1λ6.10, 150.6β, 144.1β, 141.84, 140.08, 1γλ.70, 1γλ.β6, 
138.48, 138.18, 137.56, 136.33, 135.69, 132.35, 132.07, 130.72, 130.64, 129.92, 128.25, 127.75, 
127.58, 127.11, 126.68, 126.52, 125.74, 125.61, 124.82, 123.35, 122.95, 117.83, 117.59, 116.57, 
116.29, 91.17, 88.51, 84.36, 28.33, 28.33. MALDI-TOF(m/z)μ [M−C15H24O2+H]+ calcd. for 
C123H75N3O3, 1642.58; found: 1643.49.*1 
Preparation of dimer cage 59A-j and interlocked cages 59B-j 
Trial 1: The monomer 58j (190 mg, 0.0979 mmol), CCl4 (8 mL) and CHCl3 (10 mL) were added 
to a dry Schlenk tube in glovebox. The multidentate ligand Lsi (4.8 mg, 0.012 mmol) and the 
Mo(VI) carbyne precursor (7.8 mg, 0.012 mmol) were premixed in dry carbon tetrachloride (2 
mL) for 10 minutes to generate the catalyst in situ. After the generation, the catalyst solution was 
added to the monomer solution and stirred at 55 oC in close system. The reaction was monitored 
by GPC and NMR. After overnight, the precipitates were filtered off and the liquid was 
concentrated down. The residue was washed with brine and dried over Na2SO4. The solution was 
concentrated down under reduced pressure. The residue was purified by column 
                                                          
*The Boc groups were cleaved under MALDI-TOF MS conditions. 
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(hexane/CHCl3/EtOAc, 30/20/1, v/v/v) and dimer cage 59A-j (7.0 mg, 6%) and interlocked 59B-
j cages (65.6, 59%) were collected. 
Trial 2: Follow the general alkyne metathesis procedure. Monomer 58j (102 mg, 0.0525 mmol), 
the multidentate ligand Lsi (2.5 mg, 0.0063 mmol) and the Mo(VI) carbyne precursor (4.2 mg, 
0.0063 mmol), CCl4 (10 mL) and CHCl3 (10 mL) were used. Dimer cage 59A-j (7.9 mg, 13%) 
and interlocked cage 59B-j (19.8 mg, 33%) were collected. 
Dimeric cage 59A-j: 1H NMR (500 MHz, CDCl3) δ 8.40 (d, 
J = 8.8 Hz, 6H), 8.35 (d, J = 8.7 Hz, 6H), 8.32 – 8.28 (m, 
6H), 8.26 (d, J = 1.9 Hz, 6H), 7.91 (s, 6H), 7.85 (q, J = 8.3 
Hz, 24H), 7.78 (dd, J = 8.8, 1.8 Hz, 6H), 7.74 (dd, J = 8.7, 
1.7 Hz, 6H), 1.81 (s, 54H). 13C NMR (125 MHz, CDCl3) δ 
181.87, 142.72, 140.89, 140.34, 138.40, 138.30, 136.55, 
130.96, 130.84, 128.18, 128.02, 127.12, 125.89, 125.68, 
122.62, 118.28, 118.16, 116.66, 116.47, 84.42, 28.38. Due 
to poor solubility of cage 59A-j, the 13C NMR was determined using indirect method (HSQC 
figure 4.16 and HMBC figure 4.17). MALDI-TOF(m/z)μ [M−C30H48O12+H]+ calcd. for 
C126H72N6, 1670.59; found: 1668.06. * 
Interlocked cage 59B-j: For 1H and 13C NMR see figure 4.18b and 4.19. MALDI-TOF(m/z): 
[M−C60H96O24+H]+ calcd. for C252H145N12, 3340.18; found: 3335.53. * 
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Figure 4.10. The aromatic region of variable-temperature NMR spectra of product 59B-j at 60 
oC (top), 20 oC (middle), -20 oC (bottom). The broadening of the spectrum at -20 oC may be due 
to aggregation. 
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Figure 4.11. ROESY experiment of 59B-a in CDCl3 at -50 oC with mixing time 0.3 s.  The blue 
cross peaks (except for the diagonal peaks) are due to chemical/conformational exchange. 
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4.4.4. DOSY experiment 
DOSY experiments of 59A-j and 59B-j were conducted respectively in order to study 
their relative size difference. Based on Stokes-Einstein equation (Equation 4.1), the 
thermodynamic radius of a particle is correlative with solution temperature and viscosity. In 
order to minimize the uncertain factors, DOSY experiments were done in the same solvent 
(CDCl3) and temperature (296 K), and CHCl3 solvent residue was used as internal standard. The 
DOSY experiments show very narrow diffusion constants results for both 59A-j and 59B-j. The 
measured diffusion constant of the dimeric cage 59A-j is 3.09 × 10-10 m2s-1 and that of CHCl3 is 
24.0 × 10-10 m2s-1; the diffusion constant of interlocked cage 59B-j is 1.83 × 10-10 m2s-1and that 
of CHCl3 is 19.8 × 10-10 m2s-1. 
To calculate the relative size of thermodynamic radius of dimeric cage and interlocked 
cage, Stokes-Einstein equation was used: 
� = �஻�͸��ݎ (Equation 4.1) 
D is the diffusion constant. 
T is temperature. 
kB is the Boltzmann’s constant. 
η is the viscosity of the solution. 
r is the thermodynamic radius of the particle.  
Since the experiments were conducted under same temperature, thus  ݎௗ�௠௘�ݎ�௡�௘�௟௞ = ��௡�௘�௟௞�ௗ�௠௘� ��௡�௘�௟௞�ௗ�௠௘�     (Equation 4.2) 
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CHCl3 as the internal standard was used to determine the relative viscosity difference of these 
two solutions:  
So the relative thermodynamic radiuses of the dimeric cage and interlocked cage can be 
determined: 
The relative thermodynamic volume of of dimeric cage and interlocked cage is:  
The DOSY experiments indicated that the thermodynamic radius of dimeric cage 59A-j 
is about half of the second isolated species 59B-j, which is a strong evidence showing that the 
second isolated species is indeed twice of the dimeric cage, thus very likely an interlocked 
species. But the narrow diffusion constant measured result of 59B-j still cannot prove whether 
there is only one interlocked species or two different ones since there are no big difference for 
the face-to-face and side-by-side interlocked products.  
�ௗ�௠௘���௡�௘�௟௞ = ��௡�௘�௟௞−஼�஼௟3�ௗ�௠௘�−஼�஼௟3 = ͳͻ.ͺ �ଶݏ−ଵʹͶ.Ͳ �ଶݏ−ଵ = Ͳ.ͺʹͷ       (Equation 4.3) 
ݎௗ�௠௘�ݎ�௡�௘�௟௞ = ��௡�௘�௟௞�ௗ�௠௘� ��௡�௘�௟௞�ௗ�௠௘� =   ͳͲ.ͺʹͷ ͳ.ͺ͵ �ଶݏ−ଵͶ.Ͳͻ �ଶݏ−ଵ = Ͳ.ͷͶ     (Equation 4.4) 
�ௗ�௠௘���௡�௘�௟௞ = ሺ ݎௗ�௠௘�ݎ�௡�௘�௟௞ሻଷ = ሺͲ.ͷͶሻଷ = Ͳ.ͳ͸    (Equation 4.5) 
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4.4.5. Determination of 13C NMR of cage 59A-j. 
 
Figure 4.16. The HSQC spectrum of cage 59A-j.  
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Figure 4.17. The HMBC spectrum of cage 59A-j.  
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Figure 4.18. The 1H NMR spectra of cage 59B-a (a) and 59B-j (b).  
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Figure 4.19. The 13C NMR spectra of cage 59B-j.  
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CHAPTER 5 
 
 
 
Ethynylene Linked Pyrene-based Shape-Persistent COPs:  
Research Progress and Outlook 
 
 
5.1. Introduction 
The past couple of decades have witnessed tremendous efforts devoted to the area of 
cancer cell imaging, drug delivery and targeting. Various controlled drug delivery systems have 
been developed, such as protein self-assembly cages,1-2 quantum dots,3-7 polymers,8-11 and 
lipids10,12-14. Recently, metal organic polyhedrons and frameworks have also been applied to the 
field of drug delivery. 15-19 One great advantage of these large-sized carriers is their selective 
accumulation into cancer cells due to “enhanced permeability and retention effect”,20 thus 
facilitating the imaging and reducing the general toxicity and the side effects of the active 
compound. As an alternative class of cage molecules, covalent organic polyhedrons (COPs) are 
seeking their applications beyond the well-established fields such as gas adsorption/separation21-
25
, host-guest chemistry26-30. COPs, usually with discrete and tunable pore size and easily 
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functionalized surface, could provide a novel platform for cell imaging, drug delivery and 
targeting. 
Pyrene moiety is a well-known chromophore, which has been widely used in cell imaging, 
molecular sensing and diagnosis, etc.31-36 It has also been shown that pyrene can bind with 
fullerenes via π-π stacking interactions.37 Therefore, COPs comprising pyrene moieties could be 
potentially used in fullerene separation and delivery. On the other hand, metallofullerenes, such 
as Gd@C60 and Gd3N@C60 with Gd3+ or Gd3N6+ encapsulated in the fullerene cage, have been 
explored as magnetic resonance imaging (MRI) contrast agents.38-40 One great advantage of these 
metallofullerenes is their significantly enhanced biological safety since their “cage” structure 
completely prevents the release of highly toxic Gd3+ ion into biological environment. Given the 
above consideration, we envision the pyrene-based shape-persistent molecular cages could serve 
as a “vehicle” to deliver the metallofullerenes into biosystems for imaging/diagnostic application.   
5.2. Preliminary results and discussion  
In this chapter, the design and synthesis of an ethynylene linked COP with pyrene 
moieties incorporated will be discussed. The target monomer has four arms, containing one 
carbazole on each arm to act as a vertex. The monomer was synthesized via Suzuki coupling of a 
pyrene-based center piece 61 and an iodo substituted carbazole side arm 51h. Then the monomer 
62h was subjected to alkyne metathesis catalyzed by catalyst 1 or 3 in a mixed solvent of CCl4 
and chloroform to provide the cage product. The dimeric cage formation was proved by MALDI-
TOF MS and GPC. However, the cage synthesis was not very efficient with catalyst 1 or 3. A 
large amount of oligomer byproduct remained in the reaction mixture even after 2 times of 
addition of newly generated catalyst solution, after 16 h time interval. Although the yield is low, 
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cage 63h was successfully isolated and characterized with NMR and MALDI-TOF MS. The 
MALDI-TOF MS showed clear and clean dimeric cage formation. However, the NMR showed 
more proton signals than expected (Figure 5.1). Specifically, two sets of signals in the aromatic 
region with similar peak shapes and chemical shift were observed, but the integration ratio of 
these two sets of peaks varied between different fractions after column separation (Figure 5.5). 
This observation indicated that there are likely two different cages formed in the metathesis 
reaction, with slightly different polarity. Given the fact that both products were dimeric cages, 
we believe that these are two isomers. The pyrene moiety in a monomer unit contains both a 
major axis and a minor axis. When forming a dimeric cage, there are two ways to connect two 
monomers together (Figure 5.2), forming two isomers, in which the two monomer units can be 
connected with each other in a parallel or a vertical fashion. It was observed that before any 
workup and purification right after alkyne metathesis, the ratio of these two isomers is about 1:1. 
This observation indicates that there is no much energy difference between the isomers, which is 
presumably due to the small length difference between the long axis and the short one (30% 
difference). Moreover, the carbazole arms can easily rotate along single bonds, resulting in 
similar angle strain generated in either way of connection. All the arms on each isomer are all 
identical, so each isomer exhibits one set of signal on NMR with slightly different chemical shift.  
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Figure 5.3. The fluorescence titration experiments of cage 63h with C60 and C70 (exited at 306 
nm). The concentration of 63h in toluene is 3.63 × 10-6 mol/L. Fluorescence titration spectra of 
cage 63h with addition of C60 (a) and C70 (c). (b) and (d) are plots of normalized FL at 420 nm vs. 
equivalent of fullerene (C60 and C70) added. The red curves are the fitting curves. 
Given the pyrene cage molecules in hand and the demonstrated strong fullerene binding, 
next we would like to study the behaviors of cage 63h in biological environment. However, it 
turned out working with cage 63h in biosystems is very challenging due to its highly 
hydrophobic nature. To overcome the poor solubility issue, the free carbazole based cage 63-H 
was synthesized by cleaving the long alkyl chains in basic condition (Scheme 5.2). However, the 
unsubstituted cage molecule still showed very poor solubility in aqueous solution. Later, we 
designed and synthesized another cage 63f with cleavable ester side chains (Scheme 5.3), which 
can provide carboxylic acid groups after hydrolysis, thus increasing the cage solubility in 
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aqueous solution. The synthetic route for 63f followed the similar procedure as for the synthesis 
of cage 63h.  
 
Scheme 5.2. Condition for cleavage of carbamate side chains to generate free carbazole based 
cage 63-H. 
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The carboxylic acid substituted cage 63f-COOH was successfully obtained after 
hydrolysis under basic condition. It was found that the solubility of cage 63f-COOH in water is 
indeed significantly improved, particularly in basic conditions. However, this acid-functionalized 
cage showed decreased fluorescence in aqueous solutions compared to those cases in organic 
solvent, such as DMSO and THF. Nonetheless, even with weaker fluorescence, the biological 
study showed the cellular uptake of cage 63f-COOH (Figure 5.4).  
 
Figure 5.4. Cellular uptake of cage 63f-COOH in HeLa C9 cells as determined by TIRF 
microscopy. a) cage 63f-COOH only; b) and c) 63f-COOH with H2B-mCherry (nucleus) and 
YFP-H-ras (membrane). 
 
5.3. Perspectives and recommendations for future 
5.3.1. Cage and Gd-metallofullerene complexation study for MRI contrast agent 
The pyrene-based cages 63h and 63f showed significant binding with fullerenes. The 
next step will be testing the binding behavior of cage 63 with Gd-metallofuleres. It is known that 
the metallofullerenes have quite different electronic properties compared to regular fullerenes. 
Therefore, more studies need to be conducted on the host-guest binding. If the result is promising, 
certain tumor targeting groups can be installed on the exterior of the cage to achieve selective 
targeting and imaging.  
a) b) c)
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Nevertheless, not limited to the pyrene-based cages, other COPs can also be candidates 
for serving as the “delivering vehicle” for Gd- metallofullerenes. 
5.3.2. Application of pyrene-labeled COP in the mechanism study of cellular uptake of COPs  
The mechanism of how the COPs are transferred into cells is still unknown. With pyrene-
labeled COP, the mechanism can be studied by monitoring the process with fluorescence 
microscopy. This work will be helpful for future rational design of COP-based drug carrier.   
5.4. Experimental Section 
5.4.1. Materials, general synthetic methods and biological study condition  
Reagents and solvents were purchased from commercial suppliers and used without 
further purification, unless otherwise indicated. Tetrahydrofuran (THF), toluene, CH2Cl2 and 
dimethylformamide (DMF) were purified by the MBRAUN solvent purification systems.  
All reactions were conducted under dry nitrogen in oven-dried glassware, unless 
otherwise specified. All the alkyne metathesis reactions were conducted in glovebox. The 
solvents used in alkyne metathesis were dried over 4 Å molecular sieves. Solvents were 
evaporated using a rotary evaporator after workup. Unless otherwise specified, the purity of the 
compounds was 1 95 % based on 1H NMR spectral integration. 
Flash column chromatography was performed by using a 100-150 times weight excess of 
flash silica gel 32-6γ ȝm from Dynamic Absorbants Inc. Fractions were analyzed by TLC using 
TLC silica gel Fβ54 β50 ȝm precoated-plates from Dynamic Absorbants Inc. Analytical gel 
permeation chromatography (GPC) was performed using a Viscotek GPCmaxTM, a Viscotek 
Model 3580 Differential Refractive Index (RI) Detector, a Viscotek Model 3210 UV/VIS 
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Detector and a set of two Viscotek Viscogel columns (7.8 × 30 cm, l-MBLMW-3078, and l-
MBMMW-3078 columns) with THF as the eluent at 30 °C. The analytical GPC was calibrated 
using monodisperse polystyrene standards.  
MALDI-TOF Mass spectra were obtained on the Voyager-DE™ STR Biospectrometry 
Workstation using sinapic acid (SA) as the matrix. The high resolution mass spectra were 
obtained on Waters SYNAPT G2 High Definition Mass Spectrometry System. Analyte 
molecules were diluted into ESI solvents, methanol, chloroform or acetonitrile/water mixture, for 
final concentrations of 10 ppm or lower.  The solution was injected into the electrospray 
ionization (ESI) source at a rate of 5 L/min. Either the ESI+ or ESI− mode was used in 
reference to the molecular properties. Accurate mass analysis was performed by using the Lock 
Mass calibration feature with the instrument.   
NMR spectra were taken on Inova 400 and Inova 500 spectrometers. CHCl3 (7.27 ppm), 
toluene-d8 (2.09 ppm) were used as internal references in 1H NMR, and CHCl3 (77.00 ppm) for 
13C NMR.  1H NMR data were reported in order: chemical shift, multiplicity (s, singlet; d, 
doublet; t, triplet; q, quartet; m, multiplet), coupling constants (J, Hz), number of protons. 
Images on figure 5.4 was taken for HeLa C9 cells after 24 hours of incubation from when 
the cage was added, held at 37 oC with 5% CO2 in Dulbecco's Modified Eagle's Medium with 10% 
fetal bovine serum, penicillin (1U/mL)/streptomycin(1µg/mL), and GlutaMAX. 
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5.4.2. Synthetic procedures 
 
Compound 61 was synthesized following the reported procedure 41. 1H NMR (500 MHz, CDCl3) 
δ λ.17 (s, 4H), 8.λλ (s, βH), 1.51 (s, 48H). 
Monomer 62h: Follow the previously descripted Suzuki coupling procedure. 51h (150 mg, 
0.178 mmol), 61 (29.3 mg, 0.0424 mmol), Pd(PPh3)4 (2.4 mg, 0.00212 mmol) and Na2CO3 (1 
mL, 1M aqueous solution), EtOH (1 mL) and toluene (5 mL) were used. The product was 
purified by flash column chromatography (eluting with CH2Cl2/hexane, 2/1 ~ 3/1) to give pure 
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monomer 62h (100 mg, 77%). NMR at room temperature is very broad, mainly due to 
aggregation. The 1H NMR was conducted at 59 oC and low concentration. 1H NMR (400 MHz, 
CDCl3) δ 8.50 (d, J = 8.5 Hz, 4H), 8.35-8.36 (m, 8H), 8.32 (s, 4H), 8.24 (s, 6H), 7.90 (d, J = 9.4 
Hz, 4H), 7.85 (d, J = 8.4 Hz, 8H), 7.80 (d, J = 7.3 Hz, 8H), 7.70 (d, J = 8.6 Hz, 4H), 7.56-7.71 
(td, 28H), 7.48 (t, J = 7.6 Hz, 8H), 4.61 (t, J = 6.7 Hz, 8H), 1.99 (q, J = 7.1 Hz, 8H), 1.56 (d, J = 
7.8 Hz, 8H), 1.25 (d, J = 18.1 Hz, 96H), 0.85 (t, J = 6.4 Hz, 12H). 13C NMR showed very broad 
signal thus a lot of peaks were not resolved. See figure 5.11. 
Cage 63h: To a solution of monomer 62h (100 mg, 0.033 mmol) in CCl4 (3 mL) and CHCl3 (4 
mL) was added a newly generated catalyst solution (1 mL, generated from the precursor 4.4 mg, 
0.0067 mmol and the ligand 2.7 mg, 0.0067 mmol as described previously). The reaction mixture 
was stirred at 55 oC for 18 h and then another batch of catalyst solution (1 mL, generated from 
the precursor 4.4 mg, 0.0067 mmol and the ligand 2.7 mg, 0.0067 mmol) and react for another 
20 h. The reaction was monitored by GPC. After adding another batch of catalyst (precursor 2.2 
mg, and ligand 1.3 mg) and stir for another 20 h, the volatiles removed, the residue was filtered 
and purified by flash column chromatography (eluting with hexane/CH2Cl2, 1/3), yielding cage 
product (17 mg, 26%). 1H NMR (500 MHz, CDCl3) δ 8.γβ (d, J = 8.5 Hz, 8H), 8.21 (d, J = 8.2 
Hz, 8H), 8.08 (s, 8H), 8.07 – 8.04 (m, 8H), 8.01 – 7.97 (m, 8H), 7.96 – 7.93 (m, 4H), 7.69 – 7.60 
(m, 8H), 7.59 – 7.53 (m, 8H), 4.48 (t, J = 6.7 Hz, 16H), 1.84 (d, J = 7.7 Hz, 16H), 1.43 (q, J = 
7.6, 7.0 Hz, 16H), 1.15 (t, J = 13.9 Hz, 192H), 0.83 – 0.70 (m, 24H). MALDI-TOF(m/z): [M]+ 
calcd. for C272H324N8O16, 3960.48; found, 3961.84.  
Cage 63-H: To a seal tube, 63h (2 mg) in THF (1 mL) and NaOH (30 mg) in H2O (1 mL) were 
added. The reaction was heated to 75 oC for 6 h and stirred for another 13 h at room temperature. 
After organic layer was collected by separation, the aqueous phase was extracted with CHCl3 (10 
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mL × 2) and the organic layers were combined. After the solvent was removed by reduced 
pressure, the residue was washed with hexanes to remove soluble compounds. Then the resulting 
compound passed through a short silica plug. The relatively pure product was collected. 1H NMR 
(500 MHz, THF-d8) δ 8.β7 (s, 1γH), 8.β5 (s, γH), 8.14 (s, 6.5H), 8.06 (s, 0.7H), 8.0β (s, γ.γH), 8.01 (s, 
1.5H), 7.70 – 7.64 (m, 8H), 7.58 (d, J = 8.2 Hz, 8H), 7.52 – 7.46 (m, 8H), 7.41 (d, J = 8.4 Hz, 8H). 
  
Monomer 62f: Follow typical Suzuki coupling condition. 52f (640 mg, 0.91 mmol), 1,3,6,8-
tetrabromo-pyrene (78.8 mg, 0.152 mmol), Pd(PPh3)4 (28 mg, 0.024 mmol), Na2CO3 (1.5 mL 1 
M aqueous solution), EtOH (1.5 mL) and toluene (7 mL) were used. Product was purified by 
flash chromatography (eluting with hexanes/EtOAc/CHCl3, 4/1/4~3/2/5) yielding yellow product 
(240 mg, 63%).1H NMR (500 MHz, CHCl3) δ 8.50 (s, 4H), 8.40 (s, 4H), 8.γ7 (s, 4H), 8.γ1 (s, 
2H), 7.93 (d, J = 8.2 Hz, 4H), 7.87 (d, J = 8.1 Hz, 8H), 7.84 – 7.80 (m, 8H), 7.74 – 7.56 (m, 
36H), 7.50 (t, J = 7.7 Hz, 8H), 7.45 (d, J = 8.5 Hz, 4H), 4.44 (t, J = 6.9 Hz, 8H), 4.11 (q, J = 7.1 
Hz, 8H), 2.37 (t, J = 7.2 Hz, 8H), 2.03 (dd, J = 15.8, 8.1 Hz, 8H), 1.88 – 1.73 (m, 8H), 1.22 (t, J 
= 7.1 Hz, 12H). 13C NMR (101 MHz, CHCl3) δ 1λ6.1β, 17γ.06, 144.β1, 140.40, 1γλ.λ4, 1γ8.81, 
137.57, 136.21, 132.61, 132.33, 131.90, 130.68, 129.91, 129.44, 129.29, 128.24, 127.04, 126.62, 
126.33, 125.36, 124.22, 123.79, 122.95, 122.67, 113.23, 108.72, 92.26, 87.46, 74.95, 60.36, 
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33.79, 28.44, 24.80, 22.61, 14.16. MALDI-TOF(m/z): [M]+ calcd. for C176H134N4O12, 2496.00; 
found, 2493.34.  
 
Cage 63f: To a solution of monomer 62f (175 mg, 0.070 mmol) in CCl4 (14 mL) and CHCl3 (25 
mL) was added a newly generated catalyst solution (2 mL, generated from the precursor 7.0 mg, 
0.0105 mmol and the ligand 4.3 mg, 0.0105 mmol as described previously). The reaction mixture 
was stirred at 55 oC for 18 h and then another batch of catalyst solution (1 mL, generated from 
  - 157 - 
 
the precursor 1.7 mg, 0.0026 mmol and the ligand 1.0 mg, 0.0026 mmol) and react for another 
20 h. After removing the volatiles, the residue was filtered and purified by flash column 
chromatography (eluting with hexane/EtOAc/CHCl3, 1/1/2), yielding cage product (20 mg, 20%). 
1H NMR (400 MHz, CDCl3) δ 8.β4 – 8.21 (m, 8H), 8.19 (dd, J = 4.1, 1.5 Hz, 8H), 8.13 (s, 4H), 
8.07 (s, 2H), 8.04 (s, 2H), 8.01 (s, 4H), 7.72-7.67 (m, 8H), 7.59 (dd, J = 8.6, 1.5 Hz, 8H), 7.47 
(dd, J = 8.4, 1.5 Hz, 8H), 7.34 (d, J = 8.6 Hz, 8H), 4.36 (d, J = 7.8 Hz, 8H), 4.06 (q, J = 7.2 Hz, 
16H), 2.31 (t, J = 7.2 Hz, 16H), 1.95 (p, J = 7.2 Hz, 16H), 1.73 (p, J = 7.3 Hz, 16H), 1.17 (t, J = 
7.1 Hz, 24H). 13C NMR (101 MHz, CDCl3) δ 1λ6.10, 17γ.06, 144.β0, 140.40, 139.93, 138.81, 
137.57, 136.21, 132.61, 132.33, 131.89, 130.68, 129.90, 129.43, 129.27, 128.24, 127.04, 126.62, 
126.33, 125.33, 124.19, 123.79, 122.94, 122.66, 113.23, 108.71, 92.27, 87.46, 60.36, 33.79, 
29.67, 28.44, 22.61, 14.16, 14.11, 1.00. MALDI-TOF(m/z): [M]+ calcd. for C192H164N8O16, 
2839.23; found, 2838.90.  
Cage 63f-COOH: Cage 63f (9.0 mg, 0.0032 mmol) and KOH (80 mg, 1.4 mmol) were dissolved 
in THF (0.3 mL) and MeOH (0.3 mL). After stirring for 41 h, the solvent was removed under 
reduced pressure. The residue was redissolved in water to give a suspension and the solution was 
treated with 1M HCl (~ 2 mL) to give pH=1. More precipitates formed. Then the solution was 
extracted with EtOAc (2 mL × 3). The aqueous phase turned to colorless. The organic layer was 
concentrated down to give yellow solids. 1H NMR (500 MHz, THF-d8) δ 8.γ0 (d, J = 1.6 Hz, 
4H), 8.28 (s, 8H), 8.27 (s, 4H), 8.16 (s, 4H), 8.09 (s, 2H), 8.04 (d, J = 1.8 Hz, 4H), 7.76 – 7.73 
(m, 4H), 7.73 – 7.67 (m, 12H), 7.61 (d, J = 8.6 Hz, 2H), 7.58 – 7.56 (m, 4H), 7.55 (s, 12H), 4.48 
(t, J = 6.5 Hz, 16H). The crude 1H NMR is messy on the aliphatic region. The methylene groups 
were not able to be determined in the NMR. MALDI-TOF(m/z): [M]+ calcd. for C176H132N8O16, 
2612.98; found, 2616.09.  
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Figure 5.5. The 1H NMR of the earlier (bottom) and later (top) fractions out of column, showing 
that the two isomers have little difference in their polarity. 
5.4.3. Binding study of cage 63f and 63h with fullerenes 
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Figure 5.6. The fluorescence titration experiments of cage 63f with C60 and C70 (exited at 306 
nm). The concentration of 63h in toluene is 3.00 × 10-7 mol/L. Fluorescence titration spectra of 
cage 63h with addition of C60 (a) and C70 (c). (b) and (d) are plots of normalized FL at 430.5 nm 
vs. equivalent of fullerene (C60 and C70) added. The red curves are the fitting curves. 
The fluorescence titration experiments were conducted for cage 63f with fullerenes C60 
and C70. The fluorescence of 63f is very strong and the quenching is very clear. However one 
problem is that the FL keeps decreasing after 1 e.q. of fullerene addition. The possible reason is 
that the cage sample may contain some oligomers that can have interactions with fullerenes too. 
The internal standard normalization using NMR shows about 20% impurities (the concentration 
of cage is corrected based on the internal standard). The oligomers are difficult to remove. Based 
on this quenching curve, the fitting is not quantitatively accurate. Nonetheless, the fitting results 
are shown below:  
The binding constant of cage 63f with C60 is 3.2×107 L·mol-1. 
The binding constant of cage 63f with C70 is 1.6×108 L·mol-1. 
d) 
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5.4.4. NMR spectrum of important compounds 
 
Figure 5.9. The 1H NMR spectra of monomer 62h at 20 oC (top) and 58 oC (bottom).  
 
Figure 5.10. The 1H NMR spectra of 62h under high concentration (top) and low concentration 
(bottom). 
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Figure 5.11. The 13C NMR spectrum of monomer 62h.  
 
 
Figure 5.12. The 1H NMR of the cage 63h in CDCl3 (two isomers of the cage with a little 
different ratio).  
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Figure 5.13. The 1H NMR of the cage 63f in CDCl3. 
 
Figure 5.14. The 1H NMR of the cage 64-H in THF-d8. 
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Figure 5.15. The 1H NMR of the cage 63f -COOH in THF-d8. 
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